0001839882-23-020781.txt : 20230807 0001839882-23-020781.hdr.sgml : 20230807 20230807141625 ACCESSION NUMBER: 0001839882-23-020781 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS AG CENTRAL INDEX KEY: 0001114446 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-263376 FILM NUMBER: 231146978 BUSINESS ADDRESS: STREET 1: BAHNHOFSTRASSE 45 CITY: ZURICH STATE: V8 ZIP: CH 8001 BUSINESS PHONE: 203-719-5241 MAIL ADDRESS: STREET 1: 600 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06901 424B3 1 ubs_424b3-11058.htm FORM 424B3

July 2023

Amendment No. 1 Dated August 7, 2023†

to the Pricing Supplement dated July 31, 2023

Registration Statement No. 333-263376

Filed pursuant to Rule 424(b)(3)

(To Prospectus dated May 27, 2022 and Product Supplement dated May 27, 2022)

Structured Investments

Opportunities in International and U.S. Equities

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period (the “securities”) offer the opportunity for investors to earn a contingent payment with respect to each observation period during which the closing prices of all of the underlying equities are equal to or greater than 75% of their respective initial prices, which we refer to as their respective coupon barrier levels, on each trading day during the applicable observation period. If the closing price of any underlying equity is less than its coupon barrier level on any trading day during an observation period, you will not receive any contingent payment for that observation period. As a result, investors must be willing to accept the risk of not receiving any contingent payments during the term of the securities. In addition, if the closing prices of all of the underlying equities are equal to or greater than 100% of their respective initial prices, which we refer to as their respective call threshold levels, on the last day of an observation period (each, an “observation end date”) other than the first observation end date and the final determination date, the securities will be automatically redeemed for an amount per security equal to (i) the stated principal amount plus (ii) any contingent payment otherwise payable with respect to the related observation period. If, however, on any such observation end date, the closing price of any underlying equity is less than its call threshold level, the securities will not be redeemed. Furthermore, if the final price of any underlying equity is less than 60% of its initial price, which we refer to as its downside threshold level, on the final determination date, UBS will pay you a cash payment per security that will be less than the stated principal amount, if anything, resulting in a percentage loss that is equal to the underlying return of the underlying equity with the lowest underlying return as compared to any other underlying equities (the “worst performing underlying equity”) over the term of the securities and, in extreme situations, you could lose all of your initial investment. Accordingly, the securities do not guarantee any return of principal at maturity. Investors will not participate in any appreciation of the underlying equities. Because all payments on the securities are based on the worst performing underlying equity, a decline beyond the respective coupon barrier level and/or downside threshold level, as applicable, of any underlying equity will result in few or no contingent payments and/or a loss of a significant portion and, in extreme situations, all of your initial investment even if the other underlying equities have appreciated or have not declined as much. These securities are for investors who are willing to risk their initial investment and seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of receiving no interest over the entire term of the securities. The securities are unsubordinated, unsecured debt obligations issued by UBS AG, and all payments on the securities are subject to the credit risk of UBS AG.

SUMMARY TERMS

 

Issuer:

UBS AG London Branch

Underlying equities:

American depositary receipts of British American Tobacco p.l.c. (Bloomberg Ticker: “BTI UN”)

Common stock of Philip Morris International Inc. (Bloomberg Ticker: “PM UN”)

Aggregate principal amount:

$3,000,000

Stated principal amount:

$1,000.00 per security

Issue price:

$1,000.00 per security (see “Commissions and issue price” below)

Pricing date:

July 31, 2023

Original issue date:

August 3, 2023 (3 business days after the pricing date). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days (T+2), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the securities in the secondary market on any date prior to two business days before delivery of the securities will be required, by virtue of the fact that each security initially will settle in three business days (T+3), to specify alternative settlement arrangements to prevent a failed settlement of the secondary market trade.

Maturity date:

August 5, 2026, subject to postponement for certain market disruption events and as described under “General Terms of the Securities — Market Disruption Events” and “— Payment Dates — Maturity Date” in the accompanying product supplement.

Early redemption:

If, on any observation end date (other than the first observation end date and the final determination date), the closing prices of all of the underlying equities are equal to or greater than their respective call threshold levels, the securities will be automatically redeemed for an early redemption amount on the first contingent payment date immediately following the related observation end date.

Early redemption amount:

The early redemption amount will be an amount equal to (i) the stated principal amount plus (ii) any contingent payment otherwise payable with respect to the related observation period.

Contingent payment:

●If the closing prices of all of the underlying equities are equal to or greater than their respective coupon barrier levels on each trading day during an observation period, we will pay a contingent payment of $24.375 (equivalent to 9.75% per annum of the stated principal amount) per security on the related contingent payment date.

●If the closing price of any underlying equity is less than its respective coupon barrier level on any trading day during an observation period, we will not pay a contingent payment with respect to that observation period.

Observation end dates:

October 31, 2023, January 31, 2024, April 30, 2024, July 31, 2024, October 31, 2024, January 31, 2025, April 30, 2025, July 31, 2025, October 31, 2025, February 2, 2026, April 30, 2026 and July 31, 2026, subject to postponement for non-trading days and certain market disruption events (as described under “General Terms of the Securities — Valuation Dates”, “— Final Valuation Date” and “— Market Disruption Events” in the accompanying product supplement). We also refer to July 31, 2026 as the final determination date. References in the accompanying product supplement to one or more “valuation dates” shall mean the observation end dates for purposes of the market disruption event provisions in the accompanying product supplement.

Contingent payment dates:

November 3, 2023, February 5, 2024, May 3, 2024, August 5, 2024, November 5, 2024, February 5, 2025, May 5, 2025, August 5, 2025, November 5, 2025, February 5, 2026, May 5, 2026 and the maturity date, subject to postponement for non-business days and as described under “General Terms of the Securities — Payment Dates” and “— Maturity Date” in the accompanying product supplement. References in the accompanying product supplement to one or more “payment dates” shall mean the contingent payment dates for purposes of the market disruption event provisions in the accompanying product supplement.

Observation period:

Each trading day from but excluding the prior observation end date (or the pricing date in the case of the first observation period) to and including the next following observation end date. References in the accompanying product supplement to one or more “valuation periods” shall mean the observation periods for purposes of the market disruption event provisions in the accompanying product supplement.

Payment at maturity:

●If the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels:

(i) the stated principal amount plus (ii) any contingent payment otherwise payable on the maturity date.

 

●If the final price of any underlying equity is less than its downside threshold level:

a cash payment that is less than the stated principal amount, if anything, resulting in a percentage loss that is equal to the underlying return of the worst performing underlying equity, for an amount equal to (i) the stated principal amount plus (ii) the stated principal amount times the underlying return of the worst performing underlying equity.

 

If the final price of any underlying equity is less than its downside threshold level, investors will lose a significant portion and, in extreme situations, all of their initial investment regardless of the performance of any other underlying equity.

Underlying return:

With respect to each underlying equity, the quotient, expressed as a percentage of the following formula: (final price − initial price) / initial price

Initial price:

$33.68, which is the closing price of the American depositary receipts of British American Tobacco p.l.c. on the pricing date

$99.72, which is the closing price of the common stock of Philip Morris International Inc. on the pricing date

The initial price of each underlying equity may be adjusted in the case of certain adjustment events as described herein and under “General Terms of the Securities — Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” and “— Delisting of, or Change in Law Affecting, ADRs or Termination of ADR Facility” in the accompanying product supplement.

Worst performing underlying equity:

The underlying equity with the lowest underlying return as compared to any other underlying equity

Call threshold level:

$33.68, which is equal to 100% of the initial price of the American depositary receipts of British American Tobacco p.l.c.

$99.72, which is equal to 100% of the initial price of the common stock of Philip Morris International Inc.

The call threshold level of each underlying equity may be adjusted in the case of certain adjustment events as described herein and under “General Terms of the Securities — Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” and “— Delisting of, or Change in Law Affecting, ADRs or Termination of ADR Facility” in the accompanying product supplement.

Coupon barrier level:

$25.26, which is equal to 75% of the initial price of the American depositary receipts of British American Tobacco p.l.c.

$74.79, which is equal to 75% of the initial price of the common stock of Philip Morris International Inc.

The coupon barrier level of each underlying equity may be adjusted in the case of certain adjustment events as described herein and under “General Terms of the Securities — Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” and “— Delisting of, or Change in Law Affecting, ADRs or Termination of ADR Facility” in the accompanying product supplement.

Downside threshold level:

$20.21, which is equal to 60% of the initial price of the American depositary receipts of British American Tobacco p.l.c.

$59.83, which is equal to 60% of the initial price of the common stock of Philip Morris International Inc.

The downside threshold level of each underlying equity may be adjusted in the case of certain adjustment events as described herein and under “General Terms of the Securities — Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” and “— Delisting of, or Change in Law Affecting, ADRs or Termination of ADR Facility” in the accompanying product supplement.

Final price:

The closing price of each underlying equity on the final determination date

CUSIP / ISIN:

90279GZU6 / US90279GZU65

Listing:

The securities will not be listed or displayed on any securities exchange or any electronic communications network.

Calculation Agent:

UBS Securities LLC

Commissions and issue price:

 

Price to Public(1)

Fees and Commissions(1)

Proceeds to Issuer

Per security

 

100.00%

2.00%(a)

+ 0.50%(b)

2.50%

97.50%

 

 

 

 

 

Total

 

$3,000,000.00

$75,000.00

$2,925,000.00

(1) UBS Securities LLC has agreed to purchase from UBS AG the securities at the price to public less a fee of $25.00 per $1,000.00 stated principal amount of securities. UBS Securities LLC has agreed to resell all of the securities to Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”) at an underwriting discount which reflects:

(a) a fixed sales commission of $20.00 per $1,000.00 stated principal amount of securities that Morgan Stanley Wealth Management sells and

(b) a fixed structuring fee of $5.00 per $1,000.00 stated principal amount of securities that Morgan Stanley Wealth Management sells,

each payable to Morgan Stanley Wealth Management. See “Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any)”.

The estimated initial value of the securities as of the pricing date is $924.50. The estimated initial value of the securities was determined as of the close of the relevant markets on the date hereof by reference to UBS’ internal pricing models, inclusive of the internal funding rate. For more information about secondary market offers and the estimated initial value of the securities, see “Risk Factors — Estimated Value Considerations” and “— Risks Relating to Liquidity and Secondary Market Price Considerations” beginning on page 13 of this document.

The securities involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 11.

Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this document, the accompanying product supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

The securities are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency.

You should read this document together with the accompanying product supplement and the accompanying prospectus, each of which can be accessed via the hyperlinks below, before you decide to invest.

† This amended and restated pricing supplement amends, restates and supersedes the pricing supplement related hereto dated July 31, 2023 in its entirety.

Product supplement dated May 27, 2022     Prospectus dated May 27, 2022

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Additional Information About UBS and the Securities

UBS AG (“UBS”) has filed a registration statement (including a prospectus as supplemented by a product supplement) with the Securities and Exchange Commission (the “SEC”) for the securities to which this document relates. You should read these documents and any other documents relating to this offering that UBS has filed with the SEC for more complete information about UBS and this offering. You may obtain these documents for free from the SEC website at www.sec.gov. Our Central Index Key, or CIK, on the SEC web site is 0001114446.

You may access these documents on the SEC website at www.sec.gov as follows:

♦Prospectus dated May 27, 2022:
http://www.sec.gov/Archives/edgar/data/1114446/000119312522162430/d632731d424b3.htm

♦Product supplement dated May 27, 2022:
http://www.sec.gov/Archives/edgar/data/1114446/000183988222011628/ubs2000004208_424b2-04373.htm

References to “UBS”, “we”, “our” and “us” refer only to UBS AG and not to its consolidated subsidiaries. In this document, the “securities” refers to the Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period that are offered hereby. Also, references to the “accompanying prospectus” mean the UBS prospectus titled “Debt Securities and Warrants”, dated May 27, 2022 and references to the “accompanying product supplement” mean the UBS product supplement titled “Market-Linked Securities Product Supplement”, dated May 27, 2022.

You should rely only on the information incorporated by reference or provided in this document, the accompanying product supplement or the accompanying prospectus. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this document, the accompanying product supplement or the accompanying prospectus is accurate as of any date other than the date on the front of the document.

UBS reserves the right to change the terms of, or reject any offer to purchase, the securities prior to their issuance. In the event of any changes to the terms of the securities, UBS will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case UBS may reject your offer to purchase.

In the event of any discrepancies between this document, the accompanying product supplement and the accompanying prospectus, the following hierarchy will govern: first, this document; second, the accompanying product supplement; and finally, the accompanying prospectus.

This amended and restated pricing supplement amends, restates and supersedes the pricing supplement related hereto dated July 31, 2023 in its entirety.

July 2023

Page 2

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Investment Summary

The Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026 based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc., which we refer to as the securities, provide an opportunity for investors to earn a contingent payment, which will be an amount equal to $24.375 (equivalent to 9.75% per annum of the stated principal amount) per security, with respect to each observation period on which the closing prices of all of the underlying equities are equal to or greater than 75% of their respective initial prices, which we refer to as their respective coupon barrier levels, on each trading day during the applicable observation period. The contingent payment, if any, will be payable on the relevant contingent payment date, which is the third business day after the related observation end date, except that the contingent payment date for the final observation period will be the maturity date. It is possible that the closing prices of one or more of the underlying equities could remain less than their respective coupon barrier levels for extended periods of time or even throughout the term of the securities so that you may receive few or no contingent payments.

If the closing prices of all of the underlying equities are equal to or greater than 100% of their respective initial prices, which we refer to as their respective call threshold levels, on any of the observation end dates other than the first observation end date and the final determination date, the securities will be automatically redeemed for an early redemption amount equal to (i) the stated principal amount plus (ii) any contingent payment otherwise payable with respect to the related observation period. If the securities have not previously been redeemed and the final prices of all of the underlying equities are equal to or greater than 60% of their respective initial prices, which we refer to as their respective downside threshold levels, the payment due at maturity will be (i) the stated principal amount plus (ii) any contingent payment otherwise payable with respect to the final determination date. If, however, the securities are not redeemed prior to maturity and the final price of any underlying equity is less than its respective downside threshold level, the payment due at maturity will be a cash payment that is less than the stated principal amount, if anything, resulting in a percentage loss that is equal to the underlying return of the worst performing underlying equity, for an amount equal to (i) the stated principal amount plus (ii) the stated principal amount times the underlying return of the worst performing underlying equity. The value of such cash payment will be less than 60% of the stated principal amount of the securities and could be zero. Investors in the securities must be willing to accept the risk of losing a significant portion and, in extreme situations, all of their initial investment and also the risk of not receiving any contingent payments. In addition, investors will not participate in any appreciation of the underlying equities.

July 2023

Page 3

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Key Investment Rationale

The securities offer the opportunity for investors to earn a contingent payment equal to $24.375 (equivalent to 9.75% per annum of the stated principal amount) per security, with respect to each observation period during which the closing prices of all of the underlying equities are equal to or greater than 75% of their respective initial prices, which we refer to as the coupon barrier levels, on each trading day for the applicable observation period. The securities may be redeemed early other than on the first observation end date and the final determination date for an early redemption amount equal to (i) the stated principal amount per security plus (ii) any contingent payment otherwise payable with respect to the related observation period. The payment at maturity will vary depending on the final prices, as follows:

Scenario 1

On any observation end date other than the first observation end date and the final determination date, the closing prices of all of the underlying equities are equal to or greater than their respective call threshold levels.

￭The securities will be automatically redeemed for an early redemption amount equal to (i) the stated principal amount plus (ii) any contingent payment otherwise payable with respect to the related observation period. The related contingent payment will be paid only if all of the closing prices for all of the underlying equities were equal to or greater than their respective coupon barrier levels on each trading day during the applicable observation period.

￭Investors will not participate in any appreciation of the underlying equities from their respective initial prices.

Scenario 2

The securities are not automatically redeemed prior to maturity, the closing prices of all of the underlying equities are equal to or greater than their respective coupon barrier levels on each trading day during the final observation period and the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels.

￭The payment due at maturity will be (i) the stated principal amount plus (ii) the contingent payment payable on the maturity date.

￭Investors will not participate in any appreciation of the underlying equities from their respective initial prices.

Scenario 3

The securities are not automatically redeemed prior to maturity, the closing price of any underlying equity is less than its respective coupon barrier level on any trading day during the final observation period and the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels.

￭The payment due at maturity will be the stated principal amount.

￭Investors will not participate in any appreciation of the underlying equities from their respective initial prices and will not receive a contingent payment on the maturity date.

Scenario 4

The securities are not automatically redeemed prior to maturity and the final price of any underlying equity is less than its respective downside threshold level.

￭The payment due at maturity will be a cash payment that is less than the stated principal amount, if anything, resulting in a percentage loss that is equal to the underlying return of the worst performing underlying equity, for an amount equal to (i) the stated principal amount plus (ii) the stated principal amount times the underlying return of the worst performing underlying equity.

￭Investors will lose a significant portion and, in extreme situations, all of their initial investment in this scenario.

Investing in the securities involves significant risks. You may lose a significant portion and, in extreme situations, all of your initial investment. Any payment on the securities, including payments in respect of an early redemption, contingent payment or any repayment of principal provided at maturity, is dependent on the ability of UBS to satisfy its obligations when they come due. If UBS is unable to meet its obligations, you may not receive any amounts due to you under the securities and you could lose all of your initial investment.

 

The securities will not pay a contingent payment on a contingent payment date (including the maturity date) if the closing price of any underlying equity is less than its respective coupon barrier level on any trading day during the applicable observation period. The securities will not be subject to an early redemption if the closing price of any underlying equity is less than its respective call threshold level on an observation end date (other than the first observation end date and the final determination date). If the securities are not redeemed prior to the final determination date, you will lose a significant portion and, in extreme situations, all of your initial investment at maturity if the final price of any underlying equity is less than its respective downside threshold level.

July 2023

Page 4

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Investor Suitability

The securities may be suitable for you if:

￭You fully understand the risks of an investment in the securities, including the risk of loss of all of your initial investment.

￭You can tolerate a loss of a significant portion or all of your initial investment and are willing to make an investment that may have the same downside market risk as an investment in the worst performing underlying equity.

￭You understand and accept that an investment in the securities is linked to the worst performing underlying equity and not a basket of the underlying equities and that you will be exposed to the market risk of each underlying equity on each trading day during the term of the securities.

￭You believe that the closing price of each underlying equity will be equal to or greater than its coupon barrier level on each trading day during the term of the securities.

￭You believe that the final price of each underlying equity will be equal to or greater than its downside threshold level.

￭You understand and are willing to accept that the risks of each underlying equity are not mitigated by the performance of any other underlying equity and the risks of investing in securities with a return based on the worst performing underlying equity.

￭You understand and accept that you will not participate in any appreciation in the price of any underlying equity and that any potential positive return is limited to any contingent payments.

￭You can tolerate fluctuations in the price of the securities prior to maturity that may be similar to or exceed the downside price fluctuations of the underlying equities.

￭You are willing to invest in the securities based on the call threshold levels, coupon barrier levels, downside threshold levels and contingent payment specified on the cover hereof.

￭You are willing to forgo any dividends paid on the underlying equities and you do not seek guaranteed current income from this investment.

￭You are willing to invest in securities that may be redeemed prior to the maturity date, you are otherwise willing to hold such securities to maturity, a term of approximately 36 months, and you accept that there may be little or no secondary market.

￭You understand and are willing to accept the single equity risk associated with the securities and the risks associated with the underlying equities.

￭You are willing to assume the credit risk of UBS for all payments under the securities, and understand that if UBS defaults on its obligations you may not receive any amounts due to you including any repayment of principal.

￭You understand that the estimated initial value of the securities determined by our internal pricing models is lower than the issue price and that, should UBS Securities LLC or any affiliate make secondary markets for the securities, the price (not including their customary bid-ask spreads) will temporarily exceed the internal pricing model price.

The securities may not be suitable for you if:

￭You do not fully understand the risks of an investment in the securities, including the risk of loss of all of your initial investment.

￭You require an investment designed to provide a full return of principal at maturity.

￭You cannot tolerate a loss of a significant portion or all of your initial investment, or you are not willing to make an investment that may have the same downside market risk as an investment in the worst performing underlying equity.

￭You do not understand or cannot accept that an investment in the securities is linked to the worst performing underlying equity and not a basket of the underlying equities and that you will be exposed to the market risk of each underlying equity on each trading day during the term of the securities.

￭You believe that the closing price of any underlying equity will decline during the term of the securities and is likely to be less than its respective coupon barrier level on at least one trading day during one or more of the observation periods.

￭You believe that the final price of any underlying equity is likely to be less than its downside threshold level.

￭You do not understand or cannot accept that the risks of each underlying equity are not mitigated by the performance of any other underlying equity or the risks of investing in securities with a return based on the worst performing underlying equity.

￭You seek an investment that participates in the appreciation in the prices of the underlying equities or that has unlimited return potential.

￭You cannot tolerate fluctuations in the price of the securities prior to maturity that may be similar to or exceed the downside price fluctuations of the underlying equities.

￭You are unwilling to invest in the securities based on the call threshold levels, coupon barrier levels, downside threshold levels or contingent payment specified on the cover hereof.

￭You prefer to receive the dividends paid on the underlying equities or you seek guaranteed current income from this investment.

￭You are unable or unwilling to hold securities that may be redeemed prior to the maturity date, or you are otherwise unable or unwilling to hold such securities to maturity, a term of approximately 36 months, or you seek an investment for which there will be an active secondary market.

￭You do not understand and are not willing to accept the single equity risk associated with the securities or the risks associated with the underlying equities.

￭You are not willing to assume the credit risk of UBS for all payments under the securities, including any repayment of principal.

July 2023

Page 5

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

How the Securities Work

The following diagrams illustrate the potential outcomes for the securities depending on (1) the closing prices and (2) the final prices.

Diagram #1: Observation End Dates Other Than the First Observation End Date and the Final Determination Date

 

 

Diagram #2: Payment at Maturity if No Automatic Early Redemption Occurs

 

For more information about the payout upon an early redemption or at maturity in different hypothetical scenarios, see “Hypothetical Examples” beginning on the following page.

July 2023

Page 6

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Hypothetical Examples

The below examples are based on the following terms and are purely hypothetical (the actual terms of your security are specified on the cover hereof):

Hypothetical Initial Price:

Underlying Equity A:

Underlying Equity B:

 

$50.00

$100.00

Hypothetical Call Threshold Level:

Underlying Equity A:

Underlying Equity B:

 

$50.00, which is 100% of the initial price

$100.00, which is 100% of the initial price

Hypothetical Coupon Barrier Level:

Underlying Equity A:

Underlying Equity B:

 

$37.50, which is 75% of the initial price

$75.00, which is 75% of the initial price

Hypothetical Downside Threshold Level:

Underlying Equity A:

Underlying Equity B:

 

$30.00, which is 60% of the initial price

$60.00, which is 60% of the initial price

Hypothetical Contingent Payment:

$24.375 per security (equivalent to 9.75% per annum of the stated principal amount)

Stated Principal Amount:

$1,000.00 per security

In Examples 1 and 2, the closing prices of the underlying equities fluctuate over the term of the securities and the closing prices of all of the underlying equities are equal to or greater than their respective hypothetical call threshold levels on one of the observation end dates (other than the first observation end date and the final determination date) on which the securities may be automatically redeemed. As a result, the securities are automatically redeemed on the related contingent payment date. In Examples 3, 4 and 5, the closing price of at least one underlying equity on each of the observation end dates (other than the first observation end date and the final determination date) is less than its respective call threshold level and, consequently, the securities are not automatically redeemed prior to, and remain outstanding until, maturity.

 

Example 1

Example 2

Observation Periods

Underlying Equity A

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Underlying Equity B

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Contingent Payment

Early Redemption Amount

Underlying Equity A

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Underlying Equity B

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Contingent Payment

Early Redemption Amount

#1

X. $60.00

(at or above coupon barrier level)

 

Y. $65.00 (at or above call threshold level)

X. $119.00

(at or above coupon barrier level)

 

Y. $125.00 (at or above call threshold level)

$24.375

(Not Callable)

X. $70.00

(at or above coupon barrier level)

 

Y. $75.00 (at or above call threshold level)

X. $75.00

(at or above coupon barrier level)

 

Y. $124.00 (at or above call threshold level)

$24.375

(Not Callable)

#2

X. $38.00

(at or above coupon barrier level)

 

Y. $55.00 (at or above call threshold level)

X. $116.00

(at or above coupon barrier level)

 

Y. $123.00 (at or above call threshold level)

—*

$1,024.375

X. $35.00
(below coupon barrier level)

Y. $40.00 (below call threshold level)

X. $77.00
(at or above coupon barrier level)

Y. $89.00 (below call threshold level)

$0.00

N/A

#3

N/A

N/A

N/A

N/A

X. $30.00

(below coupon barrier level)

 

Y. $60.00 (at or above call threshold level)

X. $77.50

(at or above coupon barrier level)

Y. $120.00 (at or above call threshold level)

$0.00

$1,000.00

#4 - #11

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Final Observation Period

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Payment at Maturity

N/A

N/A

July 2023

Page 7

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

* The early redemption amount includes any unpaid contingent payment with respect to the observation end date on which the closing prices for the underlying equities are equal to or greater than their respective call threshold levels and the securities are redeemed as a result.

￭In Example 1, the securities are automatically redeemed following the second observation end date as the closing prices of all of the underlying equities on the second observation end date are equal to or greater than their respective call threshold levels. As the closing prices of all of the underlying equities are equal to or greater than their respective coupon barrier levels on each trading day during the first and second observation periods, you receive a contingent payment with respect to the first and second observation periods. Following the second observation end date, you receive the early redemption amount, calculated as follows:

Stated Principal Amount + Contingent Payment = $1,000.00 + $24.375 = $1,024.375

In this example, the early redemption feature limits the term of your investment to approximately 6 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent payments. When added to the contingent payment of $24.375 received in respect of the first observation period, your total return per security in this example is $1,048.75 (a total return of 4.875% on the securities).

￭In Example 2, the securities are automatically redeemed following the third observation end date as the closing prices of all of the underlying equities on the third observation end date are equal to or greater than their respective call threshold levels. As the closing prices of all of the underlying equities are equal to or greater than their respective coupon barrier levels on each trading day during the first observation period, you receive the contingent payment of $24.375 with respect to the first observation period. As the closing price of at least one underlying equity is less than its respective coupon barrier level on at least one trading day during the second and third observation periods, you do not receive any contingent payments with respect to those observation periods. Following the third observation end date, you will receive an early redemption amount of $1,000.00, which is the stated principal amount.

In this example, the early redemption feature limits the term of your investment to approximately 9 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent payments. Further, although all of the underlying equities have appreciated by 20% from their respective initial prices on the third observation end date, you receive only $1,000.00 per security and do not benefit from such appreciation. When added to the contingent payment of $24.375 received in respect of the first observation period, your total return per security in this example is $1,024.375 (a total return of 2.4375% on the securities).

July 2023

Page 8

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Example 3

Example 4

Observation Periods

Underlying Equity A

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

 

Underlying Equity B

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Contingent Payment

Early Redemption Amount

Underlying Equity A

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

 

Underlying Equity B

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Contingent Payment

Early Redemption Amount

#1

X. $30.00

(below coupon barrier level)

Y. $45.00 (below call threshold level)

X. $60.00
(below coupon barrier level)

Y. $76.00 (below call threshold level)

$0.00

N/A

X. $25.00

(below coupon barrier level)

Y. $40.00 (below call threshold level)

X. $62.50
(below coupon barrier level)

Y. $78.00 (below call threshold level)

$0.00

N/A

#2

X. $34.00
(below coupon barrier level)

Y. $40.00 (below call threshold level)

X. $75.00
(at or above coupon barrier level)

Y. $79.00 (below call threshold level)

$0.00

N/A

X. $38.00
(at or above coupon barrier level)

Y. $40.00 (below call threshold level)

X. $62.00
(below coupon barrier level)

Y. $97.00 (below call threshold level)

$0.00

N/A

#3 - #11

X. Various
(all below coupon barrier level)

Y. Various (all below call threshold level)

X. Various
(all at or above coupon barrier level)

Y. Various (all at or above call threshold level)

$0.00

N/A

X. Various
(all below coupon barrier level)

Y. Various (all below call threshold level)

X. Various
(all below coupon barrier level)

Y. Various (all below call threshold level)

$0.00

N/A

Final Observation Period

X. $40.00
(at or above coupon barrier level)

Y. $65.00 (at or above downside threshold level)

X. $80.00
(at or above coupon barrier level)

Y. $85.00 (at or above downside threshold level)

—*

N/A

X. $30.00 (below coupon barrier level)

Y. $38.50 (at or above downside threshold level)

X. $60.00
(below coupon barrier level)

Y. $85.00 (at or above downside threshold level)

$0.00

N/A

Payment at Maturity

$1,024.375

$1,000.00

*The final contingent payment, if any, will be paid at maturity.

Examples 3, 4 and 5 illustrate the payment at maturity per security based on the final price of the worst performing underlying equity.

￭In Example 3, during each observation period prior to the final observation period, the closing price of at least one of the underlying equities is less than its respective coupon barrier level on at least one trading day. As a result, you do not receive a contingent payment with respect to any observation period. Furthermore, because the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels and the closing prices of all of the underlying equities are equal to or greater than their respective coupon barrier levels on each trading day during the final observation period, at maturity, you receive the stated principal amount plus a contingent payment with respect to the final observation period, calculated as follows:

Stated Principal Amount + Contingent Payment = $1,000.00 + $24.375 = $1,024.375

In this example, at maturity you receive the stated principal amount per security plus the contingent payment, equal to a total payment of $1,024.375 per security at maturity. Your total return per security in this example is $1,024.375 (a total return of 2.4375% on the securities).

￭In Example 4, during each observation period prior to the final observation period, the closing price of at least one of the underlying equities is less than its respective coupon barrier level on at least one trading day. As a result, you do not receive any contingent payments with respect to any observation period. Furthermore, because the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels and the closing price of at least one of the underlying equities is less than its respective coupon barrier level on at least one trading day during the final observation period, at maturity you receive only the stated principal amount of $1,000.00.

In this example, at maturity you receive the stated principal amount per security of $1,000.00 per security at maturity. Your total return per security in this example is $1,000.00 (a 0.00% total return on the securities).

July 2023

Page 9

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Example 5

Observation Periods

Underlying Equity A

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

 

Underlying Equity B

X. Lowest Hypothetical Closing Price During the Applicable Observation Period

Y. Hypothetical Closing Price on the Applicable Observation End Date or Final Determination Date

Contingent Payment

Early Redemption Amount

#1

X. $34.00

(below coupon barrier level)

 

Y. $55.00 (at or above call threshold level)

X. $79.00

(at or above coupon barrier level)

 

Y. $105.00 (at or above call threshold level)

$0.00

N/A

#2 - #11

X. Various
(all below coupon barrier level)

Y. Various (all below call threshold level)

X. Various
(all at or above coupon barrier level)

Y. Various (all at or above call threshold level)

$0.00

N/A

Final Observation Period

X. $38.00
(at or above coupon barrier level)

Y. $40.00 (at or above downside threshold level)

X. $40.00
(below coupon barrier level)

Y. $40.00 (below downside threshold level)

$0.00

N/A

Payment at Maturity

$400.00

￭In Example 5, during each observation period prior to the final observation period, the closing price of at least one of the underlying equities is less than its respective coupon barrier level on at least one trading day. As a result, you do not receive a contingent payment with respect to any observation period. Furthermore, because the final price of at least one of the underlying equities on the final determination date is less than its respective downside threshold level, you are fully exposed to the decline in the worst performing underlying equity. Your payment at maturity is calculated as follows:

= $1,000.00 + ($1,000.00 × Underlying Return of the Worst Performing Underlying Equity)

= $1,000.00 + ($1,000.00 × -60.00%)

= $400.00

In this example, because the final price of the worst performing underlying equity represents a 60.00% decline from its initial price, you will receive a total cash payment per security equal to $400.00 (a loss of 60.00% on the securities).

We make no representation or warranty as to which of the underlying equities will be the worst performing underlying equity for the purposes of calculating your actual payment at maturity.

Investing in the securities involves significant risks. The securities differ from ordinary debt securities in that UBS is not necessarily obligated to repay the full amount of your initial investment. If the securities are not redeemed prior to the final determination date, you may lose a significant portion, and in extreme situations, all of your initial investment. Specifically, if the securities are not redeemed prior to maturity and the final price of any underlying equity is less than its respective downside threshold level, UBS will pay you a cash payment per security that will be less than the stated principal amount, if anything, resulting in a percentage loss that is equal to the underlying return of the worst performing underlying equity over the term of the securities.

The securities will not pay a contingent payment if the closing price of any underlying equity is less than its respective coupon barrier level on any trading day during the applicable observation period. The securities will not be subject to an early redemption if the closing price of any underlying equity is less than its respective call threshold level on any observation end date (other than the first observation end date and the final determination date). You will be exposed to the market risk of each underlying equity on each trading day during the term of the securities (including the final determination date) and any decline in the price of one underlying equity may negatively affect your return and will not be offset or mitigated by a lesser decline or any potential increase in the price of any other underlying equity.

Any payment to be made on the securities, including any repayment of principal, depends on the ability of UBS to satisfy its obligations as they come due. If UBS were to default on its obligations you may not receive any amounts owed to you under the securities and you could lose all of your initial investment.

 

July 2023

Page 10

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

Risk Factors

The following is a non-exhaustive list of certain key risk factors for investors in the securities. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying product supplement. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the securities.

Risks Relating to Return Characteristics

￭Risk of loss at maturity. The securities differ from ordinary debt securities in that UBS will not necessarily repay the stated principal amount of the securities at maturity. If the securities are not redeemed prior to maturity, UBS will repay you the stated principal amount of your securities in cash only if the final prices of all of the underlying equities are equal to or greater than their respective downside threshold levels on the final determination date and will only make such payment at maturity. If the securities are not redeemed prior to maturity and the final price of any underlying equity is less than its respective downside threshold level, you will lose a percentage of your principal amount equal to the underlying return of the worst performing underlying equity. In this case, the payment at maturity will be significantly less than the stated principal amount and could be zero.

￭Contingent repayment of stated principal amount only at maturity. If your securities are not redeemed prior to maturity, you should be willing to hold your securities to maturity. If you are able to sell your securities prior to maturity in the secondary market, you may have to sell them at a loss relative to your initial investment even if the then-current prices of all of the underlying equities are equal to or greater than their respective downside threshold levels.

￭You may not receive any contingent payments. UBS will not necessarily make periodic payments on the securities. If the closing price of any of the underlying equities on any trading day during an observation period is less than its respective coupon barrier level, UBS will not pay you the contingent payment applicable to such observation period on the corresponding contingent payment date. If this continues for each observation period during the term of the securities, UBS will not pay you any contingent payments during the term of, and you will not receive a positive return on, your securities. Generally, this nonpayment of the contingent payment coincides with a period of greater risk of principal loss on your securities.

￭Higher contingent payments are generally associated with a greater risk of loss. Greater expected volatility with respect to, and lower expected correlation among, the underlying equities reflects a higher expectation as of the pricing date that the final price of any of the underlying equities could be less than its respective downside threshold level on the final determination date of the securities. “Volatility” refers to the frequency and magnitude of changes in the price of an underlying equity. This greater expected risk will generally be reflected in higher contingent payments for that security. However, while the contingent payment is set on the pricing date, an underlying equity’s volatility, and the correlation of the underlying equities, can change significantly over the term of the securities. The price of any of the underlying equities for your securities could fall sharply, which could result in the loss of a significant portion or all of your initial investment.

￭Reinvestment risk. The securities will be redeemed prior to maturity if the closing prices of all of the underlying equities are equal to or greater than their call threshold levels on any observation end date (other than the first observation end date and the final determination date) and you will not receive any more contingent payments after the related contingent payment date. Conversely, the securities will not be subject to an early redemption when the closing price of any of the underlying equities is less than its call threshold level on any observation end date (other than the first observation end date and the final determination date), which generally coincides with a period of greater risk of principal loss on your securities. The securities could be redeemed as early as the second contingent payment date, potentially limiting your investment to a term of approximately 6 months. In the event that the securities are redeemed prior to maturity, there is no guarantee that you will be able to reinvest the proceeds from an investment in the securities at a comparable rate of return for a similar level of risk. In addition, to the extent you are able to reinvest such proceeds in an investment comparable to the securities, you will incur transaction costs and the original issue price for such an investment is likely to include certain built‑in costs such as dealer discounts and hedging costs.

￭You will not participate in any appreciation of any underlying equity and will not have the same rights as holders of any underlying equity. You will not participate in any appreciation in any underlying equity, and the return on the securities will be limited to any contingent payment that is paid with respect to each observation period during which the closing price or the final price, as applicable, of each underlying equity is equal to or greater than its coupon barrier level on each trading day during that observation period. It is possible that the closing price of at least one of the underlying equities could be less than its coupon barrier level on at least one trading day during most or all of the observation periods so that you will receive few or no contingent payments. If you do not earn sufficient contingent payments over the term of the securities, the overall return on the securities may be less than the amount that would be paid on a conventional debt security of the issuer of comparable maturity and less than the return on a direct investment in any or all of the underlying equities. You will not have voting rights or any rights

July 2023 Page 11

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

to receive dividends or other distributions or any other rights with respect to any underlying equity. If the securities are not redeemed prior to maturity, you may be subject to the depreciation in the price of the worst performing underlying equity even though you cannot participate in any appreciation in the prices of the underlying equities.

￭Because the securities are linked to the performance of more than one underlying equity, there is an increased probability that you will not receive a contingent payment with respect to an observation period and that you will lose a significant portion or all of your initial investment. The risk that you will not receive a contingent payment with respect to an observation period and that you will lose a significant portion or all of your initial investment in the securities is greater if you invest in the securities as opposed to securities that are linked to the performance of a single underlying equity if their terms are otherwise substantially similar. With a greater total number of underlying equities, it is more likely that the closing price or the final price, as applicable, of any underlying equity will be less than its respective coupon barrier level and/or downside threshold level during any observation period or on any observation end date (including the final determination date). Therefore, it is more likely that you will receive an amount in cash which is worth less than your stated principal amount on the maturity date. In addition, if the performances of the underlying equities are not correlated to each other, the risk that the closing price or the final price, as applicable, of any underlying equity is less than its coupon barrier level or downside threshold level during any observation period or on any observation end date (including the final determination date), is even greater.

Risks Relating to Characteristics of the Underlying Equities

￭Single equity risk. The return on the securities, which may be negative, is linked to the performance of each underlying equity. The price of each underlying equity can rise or fall sharply due to factors specific to such underlying equity and its issuer (an “underlying equity issuer”), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general stock market or commodity market volatility and levels, interest rates and economic and political conditions. Recently, the coronavirus infection has caused volatility in the global financial markets and a slowdown in the global economy. Coronavirus or any other communicable disease or infection may adversely affect the underlying equity issuers and, therefore, the underlying equities. You, as an investor in the securities, should make your own investigation into the underlying equity issuers and the underlying equities. For additional information regarding each underlying equity issuer, please see “Information About the Underlying Equities” in this document and each underlying equity issuer’s SEC filings referred to in that section. We urge you to review financial and other information filed periodically by the underlying equity issuer with the SEC.

￭You are exposed to the market risk of each underlying equity. Your return on the securities is not linked to a basket consisting of the underlying equities. Rather, it will be contingent upon the performance of each underlying equity. Unlike an instrument with a return linked to a basket of underlying equities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each underlying equity. Poor performance by any underlying equity may negatively affect your return and will not be offset or mitigated by the performance of any other underlying equity. Accordingly, your investment is subject to the market risk of each underlying equity.

￭There can be no assurance that the investment view implicit in the securities will be successful. It is impossible to predict whether and the extent to which the prices of the underlying equities will rise or fall and there can be no assurance that the closing price of each underlying equity will be equal to or greater than its coupon barrier level on each trading day during an observation period, or, if the securities are not redeemed prior to maturity, that the final price of each underlying equity will be equal to or greater than its downside threshold level. The prices of the underlying equities will be influenced by complex and interrelated political, economic, financial and other factors that affect the underlying equity issuers. You should be willing to accept the risks of owning equities in general and the underlying equities in particular, and the risk of losing a significant portion or all of your initial investment.

￭No affiliation with the underlying equity issuers. The underlying equity issuers are not affiliates of ours, are not involved with the offering in any way, and have no obligation to consider your interests in taking any corporate actions that might affect the market value of, or return on, the securities. We have obtained all information regarding the underlying equities from publicly available information and have not made any due diligence inquiry with respect to the underlying equities in connection with the offering.

July 2023 Page 12

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

￭The securities are subject to sector concentration risk. The securities are subject to sector concentration risk because each underlying equity issuer operates in the same sector, as described below under “Information About the Underlying Equities”. The performance of these companies is subject to a number of complex and unpredictable factors such as government regulation, supply and demand for the products and services produced or offered by such companies and industry competition. Any negative developments may have a negative effect on the underlying equities and, in turn, may have a material adverse effect on the market value of, and return on, the securities. By investing in the securities, you will not benefit from the diversification which could result from an investment linked to the performance of companies that operate in multiple sectors.

￭Risks associated with non-U.S. markets. — An investment in securities linked directly or indirectly to the value of non-U.S. equity securities, such as the securities, involves particular risks. For example, the non-U.S. markets may be more volatile than the U.S. securities markets, and market developments may affect these markets differently from the U.S. or other securities markets. Direct or indirect government intervention to stabilize the securities markets outside the U.S., as well as cross-shareholdings in certain companies, may affect trading prices and trading volumes in those markets. Also, the public availability of information concerning the non-U.S. issuers may vary depending on their home jurisdiction and the reporting requirements imposed by their respective regulators. Securities prices generally are subject to political, economic, financial and social factors that apply to the markets in which they trade and, to a lesser extent, non-U.S. markets. Securities prices outside the U.S. are subject to political, economic, financial and social factors that apply in non-U.S. countries. These factors, which could negatively affect non-U.S. markets, include the possibility of changes in a non-U.S. government’s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other laws or restrictions applicable to non-U.S. companies or investments in non-U.S. equity securities and the possibility of fluctuations in the rate of exchange between currencies. Moreover, non-U.S. economies may differ favorably or unfavorably from the U.S. economy in important respects such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.

Non-U.S. securities may also be subject to regulatory risks, including sanctions. For instance, pursuant to U.S. executive orders, U.S. persons are prohibited from engaging in transactions in publicly traded securities of certain companies that are determined to be linked to the military, intelligence and security apparatus of the People’s Republic of China. The prohibition also covers any securities that are derivative of, or are designed to provide investment exposure to, such securities. Additionally, due to regulatory and market reasons, trading in certain Russian securities, and ETFs investing in Russian securities, has been suspended. Additionally, following certain events, if the calculation agent determines that a change in law has occurred with respect to an underlying asset, the calculation agent may take the actions described in the accompanying product supplement under “— General Terms of the Securities — Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” and “— Delisting of, or Change in Law Affecting, ADRs or Termination of ADR Facility”.

￭Exchange rate risk. The securities are linked, at least in part, to ADRs. Because ADRs are denominated in U.S. dollars but represent non-U.S. equity securities that are denominated in a non-U.S. currency, changes in currency exchange rates may negatively impact the value of the ADRs. The value of the non-U.S. currency may be subject to a high degree of fluctuation due to changes in interest rates, the effects of monetary policies issued by the U.S., non-U.S. governments, central banks or supranational entities, the imposition of currency controls or other national or global political or economic developments. Therefore, adverse changes in exchange rates may result in reduced returns for the securities.

￭There are important differences between the rights of holders of ADRs and the rights of holders of the non-U.S. stock. The securities are linked, at least in part, to ADRs. There are important differences between the rights of holders of ADRs and the non-U.S. stock represented by such ADRs. Each ADR is a security evidenced by an American depositary receipt that represents a specified number of shares of the non-U.S. stock. Generally, an ADR is issued under a deposit agreement, which sets forth the rights and responsibilities of the depositary, the non-U.S. stock issuer and holders of the ADRs, which may be different from the rights of holders of the non-U.S. stock. For example, the non-U.S. stock issuer may make distributions in respect of the non-U.S. stock that are not passed on to the holders of its ADRs. Any such differences between the rights of holders of the ADRs and holders of the non-U.S. stock may be significant and may materially and adversely affect the value of the ADRs and, as a result, the market value of, and return on, your securities.

Estimated Value Considerations

￭The issue price you pay for the securities exceeds their estimated initial value. The issue price you pay for the securities exceeds their estimated initial value as of the pricing date due to the inclusion in the issue price of the underwriting discount, hedging costs, issuance and other costs and projected profits. As of the close of the relevant markets on the pricing date, we have determined the estimated initial value of the securities by reference to our internal pricing models and the estimated initial value of the securities is set forth in this pricing supplement. The pricing models used to determine the estimated initial value of the

July 2023 Page 13

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

securities incorporate certain variables, including the levels of the underlying equities, volatility of the underlying equities, any dividends paid on the underlying equities, the correlation of the underlying equities, prevailing interest rates, the term of the securities and our internal funding rate. Our internal funding rate is typically lower than the rate we would pay to issue conventional fixed or floating rate debt securities of a similar term. The underwriting discount, hedging costs, issuance and other costs, projected profits and the difference in rates will reduce the economic value of the securities to you. Due to these factors, the estimated initial value of the securities as of the pricing date is less than the issue price you pay for the securities.

￭The estimated initial value is a theoretical price and the actual price that you may be able to sell your securities in any secondary market (if any) at any time after the pricing date may differ from the estimated initial value. The value of your securities at any time will vary based on many factors, including the factors described above and in “— Risks Relating to Characteristics of the Underlying Equities — Single equity risk” above and is impossible to predict. Furthermore, the pricing models that we use are proprietary and rely in part on certain assumptions about future events, which may prove to be incorrect. As a result, after the pricing date, if you attempt to sell the securities in the secondary market, the actual value you would receive may differ, perhaps materially, from the estimated initial value of the securities determined by reference to our internal pricing models. The estimated initial value of the securities does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your securities in any secondary market at any time.

￭Our actual profits may be greater or less than the differential between the estimated initial value and the issue price of the securities as of the pricing date. We may determine the economic terms of the securities, as well as hedge our obligations, at least in part, prior to the pricing date. In addition, there may be ongoing costs to us to maintain and/or adjust any hedges and such hedges are often imperfect. Therefore, our actual profits (or potentially, losses) in issuing the securities cannot be determined as of the pricing date and any such differential between the estimated initial value and the issue price of the securities as of the pricing date does not reflect our actual profits. Ultimately, our actual profits will be known only at the maturity of the securities.

Risks Relating to Liquidity and Secondary Market Price Considerations

￭There may be little or no secondary market for the securities. The securities will not be listed or displayed on any securities exchange or any electronic communications network. UBS Securities LLC and its affiliates intend, but are not required, to make a market for the securities and may stop making a market at any time. If you are able to sell your securities prior to maturity, you may have to sell them at a substantial loss. Furthermore, there can be no assurance that a secondary market for the securities will develop. The estimated initial value of the securities does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your securities in any secondary market at any time.

￭The price at which UBS Securities LLC and its affiliates may offer to buy the securities in the secondary market (if any) may be greater than UBS’ valuation of the securities at that time, greater than any other secondary market prices provided by unaffiliated dealers (if any) and, depending on your broker, greater than the valuation provided on your customer account statements. For a limited period of time following the issuance of the securities, UBS Securities LLC or its affiliates may offer to buy or sell such securities at a price that exceeds (i) our valuation of the securities at that time based on our internal pricing models, (ii) any secondary market prices provided by unaffiliated dealers (if any) and (iii) depending on your broker, the valuation provided on customer account statements. The price that UBS Securities LLC may initially offer to buy such securities following issuance will exceed the valuations indicated by our internal pricing models due to the inclusion for a limited period of time of the aggregate value of the underwriting discount, hedging costs, issuance costs and theoretical projected trading profit. The portion of such amounts included in our price will decline to zero on a straight line basis over a period ending no later than the date specified under “Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any)”. Thereafter, if UBS Securities LLC or an affiliate makes secondary markets in the securities, it will do so at prices that reflect our estimated value determined by reference to our internal pricing models at that time. The temporary positive differential relative to our internal pricing models arises from requests from and arrangements made by UBS Securities LLC with the selling agents of structured debt securities such as the securities. As described above, UBS Securities LLC and its affiliates are not required to make a market for the securities and may stop making a market at any time. The price at which UBS Securities LLC or an affiliate may make secondary markets at any time (if at all) will also reflect its then current bid-ask spread for similar sized trades of structured debt securities. UBS Securities LLC reflects this temporary positive differential on its customer statements. Investors should inquire as to the valuation provided on customer account statements provided by unaffiliated dealers.

￭Price of securities prior to maturity. The market price of the securities will be influenced by many unpredictable and interrelated factors, including the prices of the underlying equities; the correlation of the underlying equities; the volatility of the underlying equities; any dividends paid on the underlying equities; the time remaining to the maturity of the securities; interest rates in the

July 2023 Page 14

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

markets; geopolitical conditions and economic, financial, political, force majeure and regulatory or judicial events; the creditworthiness of UBS and the then current bid-ask spread for the securities.

￭Impact of fees and the use of internal funding rates rather than secondary market credit spreads on secondary market prices. All other things being equal, the use of the internal funding rates described above under “—Estimated Value Considerations” as well as the inclusion in the issue price of the underwriting discount, hedging costs, issuance and other costs and any projected profits are, subject to the temporary mitigating effect of UBS Securities LLC’s and its affiliates’ market making premium, expected to reduce the price at which you may be able to sell the securities in any secondary market.

Risks Relating to Hedging Activities and Conflicts of Interest

￭Potential conflicts of interest. We and our affiliates may engage in business related to any underlying equity, which may present a conflict between our obligations as issuer and you, as a holder of the securities. There are also potential conflicts of interest between you and the calculation agent, which will be an affiliate of UBS. The calculation agent will determine whether the contingent payment is payable to you on any contingent payment date, whether the securities are subject to an early redemption and the payment at maturity of the securities, if any, based on observed closing prices of the underlying equities during the observation period or on the observation end dates, as applicable. The calculation agent can postpone the determination of the initial price, closing price or final price of any underlying equity (and therefore the related contingent payment date or maturity date, as applicable) if a market disruption event occurs and is continuing, on the pricing date, on any trading day during any of the observation periods or any observation end date (including the final determination date). As UBS determines the economic terms of the securities, including the contingent payment, call threshold levels, coupon barrier levels and downside threshold levels, and such terms include the underwriting discount, hedging costs, issuance and other costs and projected profits, the securities represent a package of economic terms. There are other potential conflicts of interest insofar as an investor could potentially get better economic terms if that investor entered into exchange-traded and/or OTC derivatives or other instruments with third parties, assuming that such instruments were available and the investor had the ability to assemble and enter into such instruments. Furthermore, given that UBS Securities LLC and its affiliates temporarily maintain a market making premium, it may have the effect of discouraging UBS Securities LLC and its affiliates from recommending sale of your securities in the secondary market.

In addition, we or one of our affiliates may enter into swap agreements or related hedging activities with the dealer or its affiliates in connection with the securities, which could cause the economic interests of UBS, the dealer or our or their respective affiliates to be adverse to your interests as an investor in the securities. If the dealer or any of its affiliates conduct hedging activities for us or our affiliate in connection with the securities and earns profits in connection with such hedging activities, such profit will be in addition to the underwriting compensation it receives for the sale of the securities to you. You should be aware that the potential to receive compensation both for hedging activities and sales may create a further incentive for the dealer to sell the securities to you.

￭Hedging and trading activities by the calculation agent and its affiliates could potentially affect the value of, and any amounts payable on, the securities. The hedging or trading activities of the issuer’s affiliates and of any other hedging counterparty with respect to the securities on or prior to the pricing date and prior to maturity could adversely affect the value of, and any amounts payable on, the securities. These hedging or trading activities on or prior to the pricing date could potentially affect the initial price of any underlying equity and, as a result, its call threshold level, coupon barrier level and downside threshold level. Additionally, these hedging or trading activities during the term of the securities could potentially affect the price of any underlying equity on any trading day during any observation period (including the observation end dates and the final determination date) and, accordingly, whether a contingent payment is payable, whether the securities are redeemed early and, if the securities are not called prior to maturity, the payout to you at maturity. It is possible that these hedging or trading activities could result in substantial returns for us or our affiliates while the value of the securities declines.

￭Potentially inconsistent research, opinions or recommendations by UBS. UBS and its affiliates publish research from time to time on financial markets and other matters that may influence the market value of, and return on, the securities, or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions or recommendations expressed by UBS or its affiliates may not be consistent with each other and may be modified from time to time without notice. Investors should make their own independent investigation of the merits of investing in the securities and the underlying equities to which the securities are linked.

￭We may engage in business with or involving the underlying equity issuers without regard to your interests. We or our affiliates may presently or from time to time engage in business with the underlying equity issuers without regard to your interests and thus may acquire non-public information about the underlying equities. Neither we nor any of our affiliates

July 2023 Page 15

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

undertakes to disclose any such information to you. In addition, we or our affiliates from time to time have published and in the future may publish research reports with respect to the underlying equities, which may or may not recommend that investors buy or hold the underlying equities.

￭Potential UBS impact on an underlying equity. Trading or transactions by UBS or its affiliates in an underlying equity, listed and/or over the counter options, futures, exchange-traded funds or other instruments with return linked to the performance of that underlying equity, may adversely affect the market price(s) or level(s) of that underlying equity on any trading day during any observation period or on the final determination date and, therefore, the market value of, and return on, the securities.

￭Following certain events, the calculation agent can make adjustments to the underlying equities and terms of the securities that may adversely affect the market value of, and return on, the securities. The calculation agent may make adjustments to the initial price, downside threshold level, coupon barrier level, call threshold level, and/or final price of an underlying equity or any other term of the securities and, in some instances, may replace the underlying equity, for certain events affecting such underlying equity. However, the calculation agent will not make an adjustment in response to all events that could affect an underlying equity. If an event occurs that does not require the calculation agent to make an adjustment, the market value of, and return on, the securities may be materially and adversely affected. In addition, all determinations and calculations concerning any such adjustments will be made by the calculation agent. You should be aware that the calculation agent may make any such adjustment, determination or calculation in a manner that differs from that discussed in the accompanying product supplement or herein as necessary to achieve an equitable result. Following certain events relating to the underlying equity issuer, such as a reorganization event or a delisting or suspension of trading, the return on the securities may be based on the shares of a successor to the underlying equity issuer in combination with any cash or any other assets distributed to holders of the underlying equity, if applicable, or on the common stock issued by another company. Following a delisting (including for this purpose the OTC Bulletin Board) or termination of the ADR facility for an underlying equity, as applicable, the determination as to whether a contingent payment is payable to you on any contingent payment date, whether the securities are redeemed or the amount you receive at maturity may be based on the non-U.S. stock represented by the ADRs as described under “General Terms of the Securities — Delisting of ADRs or Termination of ADR Facility” in the accompanying product supplement. The occurrence of any such event and the consequent adjustments may materially and adversely affect the value of, and return on, the securities. For more information, see the sections “General Terms of the Securities — Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset”, “— Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset” and “— Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity” in the accompanying product supplement.

Risks Relating to General Credit Characteristics

￭Credit risk of UBS. The securities are unsubordinated, unsecured debt obligations of UBS and are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment of principal at maturity, depends on the ability of UBS to satisfy its obligations as they come due. As a result, UBS’ actual and perceived creditworthiness may affect the market value of the securities. If UBS were to default on its obligations, you may not receive any amounts owed to you under the terms of the securities and you could lose all of your initial investment.

￭The securities are not bank deposits. An investment in the securities carries risks which are very different from the risk profile of a bank deposit placed with UBS or its affiliates. The securities have different yield and/or return, liquidity and risk profiles and would not benefit from any protection provided to deposits.

￭If UBS experiences financial difficulties, FINMA has the power to open restructuring or liquidation proceedings in respect of, and/or impose protective measures in relation to, UBS, which proceedings or measures may have a material adverse effect on the terms and market value of the securities and/or the ability of UBS to make payments thereunder. The Swiss Financial Market Supervisory Authority (“FINMA”) has broad statutory powers to take measures and actions in relation to UBS if (i) it concludes that there is justified concern that UBS is over-indebted or has serious liquidity problems or (ii) UBS fails to fulfill the applicable capital adequacy requirements (whether on a standalone or consolidated basis) after expiry of a deadline set by FINMA. If one of these pre-requisites is met, FINMA is authorized to open restructuring proceedings or liquidation (bankruptcy) proceedings in respect of, and/or impose protective measures in relation to, UBS. The Swiss Banking Act grants significant discretion to FINMA in connection with the aforementioned proceedings and measures. In particular, a broad variety of protective measures may be imposed by FINMA, including a bank moratorium or a maturity postponement, which measures may be ordered by FINMA either on a stand-alone basis or in connection with restructuring or liquidation proceedings. The resolution regime of the Swiss Banking Act is further detailed in Ordinance of 30 August 2012 of FINMA on the Insolvency of Banks and Securities Dealers, as amended (the “Swiss Banking Insolvency Ordinance”). In restructuring proceedings, FINMA, as

July 2023 Page 16

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

resolution authority, is competent to approve the resolution plan. The resolution plan may, among other things, provide for (a) the transfer of all or a portion of UBS’ assets, debts, other liabilities and contracts (which may or may not include the contractual relationship between UBS and the holders of securities) to another entity, (b) a stay (for a maximum of two business days) on the termination of contracts to which UBS is a party, and/or the exercise of (w) rights to terminate, (x) netting rights, (y) rights to enforce or dispose of collateral or (z) rights to transfer claims, liabilities or collateral under contracts to which UBS is a party, (c) the conversion of UBS’ debt and/or other obligations, including its obligations under the securities, into equity (a “debt-to-equity” swap), and/or (d) the partial or full write-off of obligations owed by UBS (a “write-off”), including its obligations under the securities. The Swiss Banking Insolvency Ordinance provides that a debt-to-equity swap and/or a write-off of debt and other obligations (including the securities) may take place only after (i) all debt instruments issued by UBS qualifying as additional tier 1 capital or tier 2 capital have been converted into equity or written-off, as applicable, and (ii) the existing equity of UBS has been fully cancelled. While the Swiss Banking Insolvency Ordinance does not expressly address the order in which a write-off of debt instruments other than debt instruments qualifying as additional tier 1 capital or tier 2 capital should occur, it states that debt-to-equity swaps should occur in the following order: first, all subordinated claims not qualifying as regulatory capital; second, all other claims not excluded by law from a debt-to-equity swap (other than deposits); and third, deposits (in excess of the amount privileged by law). However, given the broad discretion granted to FINMA as the resolution authority, any restructuring plan in respect of UBS could provide that the claims under or in connection with the securities will be partially or fully converted into equity or written-off, while preserving other obligations of UBS that rank pari passu with, or even junior to, UBS’ obligations under the securities. Consequently, the exercise of any such powers by FINMA or any suggestion of any such exercise could materially adversely affect the rights of holders of the securities, the price or value of their investment in the securities and/or the ability of UBS to satisfy its obligations under the securities and could lead to holders losing some or all of their investment in the securities. In the case of restructuring proceedings with respect to a systemically important Swiss bank (such as UBS), the creditors whose claims are affected by the restructuring plan will not have a right to vote on, reject, or seek the suspension of the restructuring plan. In addition, if a restructuring plan has been approved by FINMA, the rights of a creditor to seek judicial review of the restructuring plan (e.g., on the grounds that the plan would unduly prejudice the rights of holders of securities or otherwise be in violation of the Swiss Banking Act) are very limited. In particular, a court may not suspend the implementation of the restructuring plan. Furthermore, even if a creditor successfully challenges the restructuring plan, the court can only require the relevant creditor to be compensated ex post and there is currently no guidance as to on what basis such compensation would be calculated or how it would be funded.

Risks Relating to U.S. Federal Income Taxation

￭Uncertain tax treatment. Significant aspects of the tax treatment of the securities are uncertain. You should consult your tax advisor about your tax situation. See “Tax Considerations” herein and “Material U.S. Federal Income Tax Consequences”, including the section “— Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons”, in the accompanying product supplement.

July 2023 Page 17

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Information About the Underlying Equities

All disclosures contained in this document regarding each underlying equity for the securities are derived from publicly available information. UBS has not conducted any independent review or due diligence of any publicly available information with respect to any underlying equity. You should make your own investigation into each underlying equity.

Included on the following pages is a brief description of each underlying equity. This information has been obtained from publicly available sources. Set forth below is a table that provides the quarterly closing high and quarterly closing low for each underlying equity. The information given below is for the specified calendar quarters. We obtained the closing price information set forth below from Bloomberg Professional® service (“Bloomberg”), without independent verification. You should not take the historical prices of the underlying equities as an indication of future performance.

British American Tobacco p.l.c.

According to publicly available information, British American Tobacco p.l.c. (“British American Tobacco”) is a consumer goods company that provides tobacco and nicotine products. Information filed by British American Tobacco with the SEC can be located by reference to its SEC file number: 001-38159, or its CIK Code: 0001303523. British American Tobacco’s American depositary receipts are listed on the New York Stock Exchange under the ticker symbol “BTI”.

Information from outside sources is not incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. UBS has not conducted any independent review or due diligence of any publicly available information with respect to any underlying equity.

Information as of market close on July 31, 2023:

Bloomberg Ticker Symbol:

BTI UN <Equity>

52 Week High (on December 5, 2022):

$42.35

Current Price:

$33.68

52 Week Low (on May 31, 2023):

$31.71

52 Weeks Ago (on July 29, 2022):

$39.17

 

 

July 2023 Page 18

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Historical Information

The table below sets forth the published high and low closing prices, as well as end-of-quarter closing price, of the underlying equity for the specified period. The closing price of the underlying equity on July 31, 2023 was $33.68. The associated graph shows the closing prices of the underlying equity for each day from July 25, 2017 to July 31, 2023. The dotted lines represent its downside threshold level of $20.21, its coupon barrier level of $25.26 and its call threshold level of $33.68, which are equal to 60%, 75% and 100%, respectively, of its initial price. We obtained the information in the table below from Bloomberg without independent verification. UBS has not undertaken an independent review or due diligence of any publicly available information obtained from Bloomberg. The historical performance of the underlying equity should not be taken as an indication of its future performance, and no assurance can be given as to the closing price of the underlying equity at any time during the term of the securities.

British American Tobacco p.l.c.

High

Low

Period End

2019

 

 

 

First Quarter

$42.20

$31.41

$41.72

Second Quarter

$41.43

$34.67

$34.87

Third Quarter

$38.96

$34.18

$36.90

Fourth Quarter

$42.80

$34.32

$42.46

2020

 

 

 

First Quarter

$45.48

$27.64

$34.19

Second Quarter

$41.21

$35.07

$38.82

Third Quarter

$39.54

$33.22

$36.15

Fourth Quarter

$39.30

$31.83

$37.49

2021

 

 

 

First Quarter

$39.81

$35.06

$38.74

Second Quarter

$40.51

$37.35

$39.31

Third Quarter

$39.52

$35.28

$35.28

Fourth Quarter

$37.56

$33.65

$37.41

2022

 

 

 

First Quarter

$47.18

$37.97

$42.16

Second Quarter

$45.21

$40.72

$42.91

Third Quarter

$43.28

$35.50

$35.50

Fourth Quarter

$42.35

$36.20

$39.98

2023

 

 

 

First Quarter

$40.69

$34.60

$35.12

Second Quarter

$37.34

$31.71

$33.20

Third Quarter (through July 31, 2023)

$34.22

$32.83

$33.68

 

July 2023 Page 19

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

British American Tobacco p.l.c.– Daily Closing Prices
July 25, 2017 to July 31, 2023

July 2023 Page 20

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Philip Morris International Inc.

According to publicly available information, Philip Morris International Inc. (“Philip Morris”), through its subsidiaries and affiliates, is engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories and other nicotine-containing products in markets outside the United States. Information filed by Philip Morris with the SEC can be located by reference to its SEC file number: 001-33708, or its CIK Code: 0001413329. Philip Morris’ common stock is listed on the New York Stock Exchange under the ticker symbol “PM”.

Information from outside sources is not incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. UBS has not conducted any independent review or due diligence of any publicly available information with respect to any underlying equity.

Information as of market close on July 31, 2023:

Bloomberg Ticker Symbol:

PM UN <Equity>

52 Week High (on February 1, 2023):

$105.39

Current Price:

$99.72

52 Week Low (on September 30, 2022):

$83.01

52 Weeks Ago (on July 29, 2022):

$97.15

 

 

July 2023 Page 21

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Historical Information

The table below sets forth the published high and low closing prices, as well as end-of-quarter closing price, of the underlying equity for the specified period. The closing price of the underlying equity on July 31, 2023 was $99.72. The associated graph shows the closing prices of the underlying equity for each day from January 1, 2013 to July 31, 2023. The dotted lines represent its downside threshold level of $59.83, its coupon barrier level of $74.79 and its call threshold level of $99.72, which are equal to 60%, 75% and 100%, respectively, of its initial price. We obtained the information in the table below from Bloomberg without independent verification. UBS has not undertaken an independent review or due diligence of any publicly available information obtained from Bloomberg. The historical performance of the underlying equity should not be taken as an indication of its future performance, and no assurance can be given as to the closing price of the underlying equity at any time during the term of the securities.

Philip Morris International Inc.

High

Low

Period End

2019

 

 

 

First Quarter

$91.91

$66.44

$88.39

Second Quarter

$88.20

$76.65

$78.53

Third Quarter

$88.73

$71.20

$75.93

Fourth Quarter

$86.31

$76.37

$85.09

2020

 

 

 

First Quarter

$89.64

$59.98

$72.96

Second Quarter

$77.96

$67.78

$70.06

Third Quarter

$81.94

$69.99

$74.99

Fourth Quarter

$86.09

$70.04

$82.79

2021

 

 

 

First Quarter

$90.99

$79.06

$88.74

Second Quarter

$100.50

$88.06

$99.11

Third Quarter

$106.10

$94.79

$94.79

Fourth Quarter

$98.85

$85.94

$95.00

2022

 

 

 

First Quarter

$111.90

$88.87

$93.94

Second Quarter

$108.57

$95.66

$98.74

Third Quarter

$101.72

$83.01

$83.01

Fourth Quarter

$104.30

$84.00

$101.21

2023

 

 

 

First Quarter

$105.39

$90.27

$97.25

Second Quarter

$101.51

$90.01

$97.62

Third Quarter (through July 31, 2023)

$100.49

$97.19

$99.72

 

July 2023 Page 22

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Philip Morris International Inc. – Daily Closing Prices
January 1, 2013 to July 31, 2023

This document relates only to the securities offered hereby and does not relate to the underlying equities or other securities linked to the underlying equities. We have derived all disclosures contained in this document regarding the underlying equities from the publicly available documents described in the preceding paragraphs. In connection with the offering of the securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying equities.

Neither the issuer nor any of its affiliates makes any representation to you as to the performance of the underlying equities.

July 2023 Page 23

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Additional Information About the Securities

Please read this information in conjunction with the summary terms on the front cover of this document.

Additional Provisions:

 

Record date:

The record date for each contingent payment date shall be the date one business day prior to such scheduled contingent payment date; provided, however, that any contingent payment payable at maturity or upon early redemption shall be payable to the person to whom the payment at maturity or early redemption amount, as the case may be, shall be payable.

Trustee:

U.S. Bank Trust National Association

Calculation agent:

UBS Securities LLC

Tax considerations:

The U.S. federal income tax consequences of your investment in the securities are uncertain. There are no statutory provisions, regulations, published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the securities. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion in “Material U.S. Federal Income Tax Consequences”, including the section “— Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons”, in the accompanying product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the “Code”), final, temporary and proposed U.S. Department of the Treasury (the “Treasury”) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the “IRS”) has been sought as to the U.S. federal income tax consequences of your investment in the securities, and the following discussion is not binding on the IRS.

U.S. Tax Treatment. Pursuant to the terms of the securities, UBS and you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to characterize the securities as prepaid derivative contracts with respect to the underlying equities. If your securities are so treated, any contingent payment that is paid by UBS (including on the maturity date or upon early redemption) should be included in your income as ordinary income in accordance with your regular method of accounting for U.S. federal income tax purposes.

In addition, excluding amounts attributable to any contingent payment, you should generally recognize capital gain or loss upon the taxable disposition of your securities in an amount equal to the difference between the amount you receive at such time (other than amounts or proceeds attributable to a contingent payment or any amount attributable to any accrued but unpaid contingent payment) and the amount you paid for your securities. Such gain or loss should generally be long-term capital gain or loss if you have held your securities for more than one year (otherwise such gain or loss should be short-term capital gain or loss). The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the sale or exchange of your securities prior to a contingent payment date, but that could be attributed to an expected contingent payment, could be treated as ordinary income. You should consult your tax advisor regarding this risk.

Based on certain factual representations received from us, our special U.S. tax counsel, Cadwalader, Wickersham & Taft LLP, is of the opinion that it would be reasonable to treat your securities in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the securities, it is possible that your securities could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the securities could differ materially and adversely from the treatment described above, as described further under “Material U.S. Federal Income Tax Consequences”, including the section “— Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons”, in the accompanying product supplement.

Except to the extent otherwise required by law, UBS intends to treat your securities for U.S. federal income tax purposes in accordance with the treatment described above and under “Material U.S. Federal Income Tax Consequences”, including the section “— Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons”, in the accompanying product supplement unless and until such time as the IRS and the Treasury determine that some other treatment is more appropriate.

Section 1297. We will not attempt to ascertain whether any underlying equity issuer would be treated as a “passive foreign investment company” (a “PFIC”) within the meaning of Section 1297 of the Code. If an underlying equity issuer were so treated, certain adverse U.S. federal income tax consequences might apply, including possible treatment of the securities, in whole or in part, as a constructive ownership transaction, as discussed further under “Material U.S. Federal Income Tax Consequences — Securities Treated as Prepaid Derivatives or Prepaid Forwards — Section 1260” in the accompanying product supplement. You should refer to information filed with the SEC or the equivalent governmental authority by such entity and consult your tax advisor regarding the possible consequences to you in the event that an underlying equity issuer is or becomes a PFIC.

July 2023 Page 24

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Notice 2008-2. In 2007, the IRS released a notice that may affect the taxation of holders of the securities. According to Notice 2008-2, the IRS and the Treasury are actively considering whether the holder of an instrument such as the securities should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the securities will ultimately be required to accrue income currently in excess of any receipt of contingent payments and this could be applied on a retroactive basis. The IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special “constructive ownership rules” of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance and potential impact of the above considerations.

Medicare Tax on Net Investment Income. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their “net investment income,” which may include any income or gain realized with respect to the securities, to the extent of their net investment income that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the income tax. U.S. holders should consult their tax advisors as to the consequences of the 3.8% Medicare tax.

Specified Foreign Financial Assets. Certain U.S. holders that own “specified foreign financial assets” in excess of an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax advisors as to the application of this legislation to their ownership of the securities.

Non-U.S. Holders. The U.S. federal income tax treatment of the contingent payments is unclear. Subject to Section 871(m) of the Code and FATCA, as discussed below, our special U.S. tax counsel is of the opinion that contingent payments paid to a non-U.S. holder that provides us (and/or the applicable withholding agent) with a fully completed and validly executed applicable IRS Form W-8 should not be subject to U.S. withholding tax and we do not intend to withhold any tax on contingent payments. However, it is possible that the IRS could assert that such payments are subject to U.S. withholding tax, or that another withholding agent may otherwise determine that withholding is required, in which case we or the other withholding agent may withhold up to 30% on such payments (subject to reduction or elimination of such withholding tax pursuant to an applicable income tax treaty). We will not pay any additional amounts in respect of such withholding. Subject to Section 897 of the Code and Section 871(m) of the Code, discussed herein, gain realized from the taxable disposition of a security generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by the non-U.S. holder in the U.S., (ii) the non-U.S. holder is a non-resident alien individual and is present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied, or (iii) the non-U.S. holder has certain other present or former connections with the U.S.

Section 897. We will not attempt to ascertain whether an underlying equity issuer would be treated as a “United States real property holding corporation” (“USRPHC”) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the securities should be treated as “United States real property interests” (“USRPI”) as defined in Section 897 of the Code. If an underlying equity issuer and the securities were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a security upon a taxable disposition of the security to the U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition may be subject to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of such underlying equity issuer as a USRPHC and the securities as USRPI.

Section 871(m). A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain “dividend equivalents” paid or deemed paid to a non-U.S. holder with respect to a “specified equity-linked instrument” that references one or more dividend-paying U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (“delta-one specified equity-linked instruments”) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2025.

Based on our determination that the securities are not “delta-one” with respect to any underlying equity, our special U.S. tax counsel is of the opinion that the securities should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations made on the date the terms of the securities are set. If withholding is required, we will not make payments of any additional amounts.

July 2023 Page 25

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

Nevertheless, after the date the terms are set, it is possible that your securities could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the underlying equities or your securities, and following such occurrence your securities could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the securities under these rules if you enter, or have entered, into certain other transactions in respect of the underlying equities or the securities. If you enter, or have entered, into other transactions in respect of the underlying equities or the securities, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your securities in the context of your other transactions.

Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the securities, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the securities.

Foreign Account Tax Compliance Act. Legislation commonly referred to as the Foreign Account Tax Compliance Act (“FATCA”) generally imposes a withholding tax of 30% on payments to certain non-U.S. entities (including financial intermediaries) with respect to certain financial instruments, unless various U.S. information reporting and due diligence requirements have been satisfied. An intergovernmental agreement between the U.S. and the non-U.S. entity’s jurisdiction may modify these requirements. This legislation generally applies to certain financial instruments that are treated as paying U.S.-source interest or other U.S.-source “fixed or determinable annual or periodical” income (“FDAP income”). Withholding (if applicable) applies to payments of U.S.-source FDAP income but, pursuant to certain Treasury regulations and IRS guidance, does not apply to payments of gross proceeds on the disposition (including upon retirement) of financial instruments. As the treatment of the securities is unclear, it is possible that any contingent payment with respect to the securities could be subject to the FATCA rules. If withholding applies to the securities, we will not be required to pay any additional amounts with respect to amounts withheld. Both U.S. and non-U.S. holders should consult their tax advisors regarding the potential application of FATCA to the securities.

Proposed Legislation. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of securities similar to the securities purchased after the bill was enacted to accrue interest income over the term of such securities despite the fact that there may be no interest payments over the term of such securities.

Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation generally would have been to require instruments such as the securities to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.

It is not possible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your securities. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your securities.

Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to their particular situations, as well as any tax consequences of the purchase, beneficial ownership and disposition of the securities arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including those of the underlying equity issuers).

Use of proceeds and hedging:

We will use the net proceeds we receive from the sale of the securities for the purposes we describe in the accompanying product supplement under “Use of Proceeds and Hedging.” We and/or our affiliates may also use those proceeds in transactions intended to hedge our obligations under the securities as described below.

In connection with the sale of the securities, we and/or our affiliates may enter into hedging transactions involving the execution of long-term or short-term interest rate swaps, futures and option transactions or purchases and sales of securities before, on and after the pricing date of the securities. From time to time, we and/or our affiliates may enter into additional hedging transactions or unwind those we have entered into. In addition, we or one of our affiliates may enter into swap agreements or related hedging activities with the dealer or its affiliates.

We and/or our affiliates may acquire a long or short position in securities similar to the securities from time to time and may, in our or their sole discretion, hold or resell those securities.

The hedging activity discussed above may adversely affect the market value of the securities from time to time and payment on the securities, including any payment at maturity. See “Risk Factors — Risks Relating to Hedging Activities and Conflicts of Interest” in this document for a discussion of these adverse effects.

Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any):

Pursuant to the terms of a distribution agreement, UBS has agreed to sell to UBS Securities LLC, and UBS Securities LLC has agreed to purchase from UBS, the stated principal amount of the securities specified on the front cover of this document at the price to public less a fee of $25.00 per $1,000.00 stated principal amount of securities. UBS Securities LLC has agreed to resell all of the securities to Morgan Stanley Wealth Management with an underwriting discount of $25.00 reflecting a fixed sales commission of $20.00 and a fixed structuring fee of $5.00 per $1,000.00 stated principal amount of securities that Morgan Stanley Wealth Management sells. UBS or an affiliate will also pay a fee to LFT Securities, LLC, an entity in which an affiliate of Morgan Stanley Wealth Management and an affiliate of UBS Securities LLC each has an ownership interest, for providing certain electronic platform services with respect to this offering.

July 2023 Page 26

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

UBS, UBS Securities LLC or any other affiliate of UBS may use this document, the accompanying product supplement and the accompanying prospectus in a market-making transaction for any securities after their initial sale. In connection with the offering, UBS, UBS Securities LLC, any other affiliate of UBS or any other securities dealers may distribute this document, the accompanying product supplement and the accompanying prospectus electronically. Unless UBS or its agent informs the purchaser otherwise in the confirmation of sale, this document, the accompanying product supplement and the accompanying prospectus are being used in a market-making transaction.

Conflicts of Interest. UBS Securities LLC is an affiliate of UBS and, as such, has a “conflict of interest” in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (“FINRA”) Rule 5121. In addition, UBS will receive the net proceeds (excluding the underwriting discount) from the initial public offering of the securities and, thus creates an additional conflict of interest within the meaning of FINRA Rule 5121. UBS Securities LLC is not permitted to sell securities in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.

UBS Securities LLC and its affiliates may offer to buy or sell the securities in the secondary market (if any) at prices greater than UBS’ internal valuation. The value of the securities at any time will vary based on many factors that cannot be predicted. However, the price (not including UBS Securities LLC’s or any affiliate’s customary bid-ask spreads) at which UBS Securities LLC or any affiliate would offer to buy or sell the securities immediately after the pricing date in the secondary market is expected to exceed the estimated initial value of the securities as determined by reference to our internal pricing models. The amount of the excess will decline to zero on a straight line basis over a period ending no later than 6 weeks after the pricing date, provided that UBS Securities LLC may shorten the period based on various factors, including the magnitude of purchases and other negotiated provisions with selling agents. Notwithstanding the foregoing, UBS Securities LLC and its affiliates are not required to make a market for the securities and may stop making a market at any time. For more information about secondary market offers and the estimated initial value of the securities, see “Risk Factors — Estimated Value Considerations” and “— Risks Relating to Liquidity and Secondary Market Price Considerations” in this document.

Prohibition of sales to EEA & UK retail investors:

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (“EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU, as amended (“MiFID II”); (ii) a customer within the meaning of Directive 2002/92/EC, as amended, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Directive 2003/71/EC, as amended. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the “EU PRIIPs Regulation”) for offering or selling the securities or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the securities or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (the “UK”). For these purposes, a retail investor in the UK means a person who is one (or more) of: (i) a retail client as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, subject to amendments made by the Markets in Financial Instruments (Amendment) (EU Exit) Regulations 2018 (SI 2018/1403), as may be amended or superseded from time to time (the “EUWA”); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the “FSMA”) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined in Article 2 of the Prospectus Regulation as it forms part of domestic law by virtue of the EUWA (“UK Prospectus Regulation”). Consequently, no key information document required by the PRIIPs Regulation as it forms part of UK domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the securities or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the securities or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

Validity of the securities:

In the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, as special counsel to the issuer, when the securities offered by this pricing supplement have been executed and issued by the issuer and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the securities will be valid and binding obligations of the issuer, enforceable against the issuer in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors’ rights generally, and to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Swiss law, Fried, Frank, Harris, Shriver & Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by Homburger AG, Swiss legal counsel for the issuer, in its opinion dated March 8, 2022 filed on that date with the Securities and Exchange Commission as Exhibit 5.3 to the issuer’s registration statement on Form F-3 (the “Registration Statement”). In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the indenture and, with respect to the securities, authentication

July 2023 Page 27

 

Principal at Risk Contingent Income Auto-Callable Securities with Daily Coupon Observation and 6-Month Initial Non-Call Period due August 5, 2026

$3,000,000 Based on the worst performing of the American depositary receipts of British American Tobacco p.l.c. and the common stock of Philip Morris International Inc.

 

of the securities and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP dated March 8, 2022 filed with the Securities and Exchange Commission as Exhibit 5.4 to the Registration Statement.

 

July 2023 Page 28

 

 EX-FILING FEES 2 ex-filingfees.htm EXHIBIT 107.1

 

Exhibit 107.1

 

The pricing supplement to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price for such offering is $3,000,000.

 

 

 GRAPHIC 3 image1.gif GRAPHIC begin 644 image1.gif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

?W[7]>&<0U+.$)G=2HO^298OHF]JV(*@( %C# .C07P<(4M_-BWO,$) ME&V @[\706'>+Y@$Q[9H+#1"Z=8Q5!UY!T^FK4.(^!)]A6Q2(^:70C+[ELT M;>N*??QC@F8"$7$8@Q)@O-O:#\\5&B@,@L^IIG6M*>B) GRAPHIC 4 image2.gif GRAPHIC begin 644 image2.gif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

YT(;NZA'Z!NBS#B#+!9@S@^)M&P%S5A"'[K4IJ:J$_@&:J7" TL,$+7*V4!T :*1E>\::R?)08+$ @ M 6# JY%R@ ?,X "6<"K'S 1 UTB!@+&-[( :'"7:"-FOIGLMD/\"-,72 M3(&V0 8P;:30N@8G=O* &;#DI!3YS4MY<:QGD!1E,YL!U)[WL@$ [#[#H #' MEK>M8Z!D9D_;W $P,HUM_8 81+L [K:!M06"[18?Y07^-O(#[GT4_=(; L M^*K=*NK$DOK4)C>Y!JZPMY#C= %.MD$- I#B>==ZXU&6-%)BG7$;S& ! 0#Y M 1AP@/W2X-$+.,"K9U" F1]E ?Z-P0 8D)0^5WC%#PBV4[R]%*?O.NKD/H # M]OOF ;<:Y+ &@,:3\N(#K+OI 2#Z @J@<08$ (5'\ ('UEN]?@ 3^WM0.0 M;8,8R%SNL\1VE <;K/NN:+OSD DJ)ZNT^][<8&N>H'H/%6.X7WPI9\B_/[ M\*=H_2F^MX&RAS_ANB?%Y4V9, S8#O)X(R7FNFXS[2O.^*/,/O*VUGW./9X4 M!T!:(&9?,=:IWF+J5__7WT_[TE&_UL\?-O2COS^9/W"&O,G_H YH.\^Y&("$^,5]2/-H *D4!LF"U'2$- M#AL61ED'@N$7_IX#^M<.0D7Q/46+T9I20-\#QEK:E2',":'B+9ZSK> 6+H6- M_=F$45P'SIH6GN%1_" 9UF"+"6(8VESK2>%9*6%A,:$31N*"C1A0,2(UP6$, M/B#RN5X6>A\!ZIH7)H4?5M@+?."F2& /;MP=$I\?QJ I7IL1MB'%#0#M.=\( M2B LIA Y*%2[*$NFB$8YA<@*IP>0MH$JN*[':(8LJ$E*E9-?!8D3A4&"(!> M)0 %<)4 8$!I6>-C78! :)5 7$ &* $,"I!5DE-J,771R+25TLCB$>%O\B M%H+B*HZB!S9;E%'<,=JA!;9B"N)CP+VC(4:9 X @ -2A+$99J^7C*GJB)WZ: M(AKB,"*C4G@=+^[:(39D'R[C$:KC1.G8@?&857GCM5# -%;C-4JB4Q& .((C M (@C.9KCJ9T9Q'CD^;29&!X%W=T;,R*%ZBFD%A[@GB6% E9;/09CAN57'?XD M4I"?'$(<"$9%&G;@4JYAS558F]$ XCW%B^6=";HC4W"@#;A@$ (@ 2+E1"X> M$!99]CGE0 XB$-J $,X@1]KD2SDB845C!F &AC4YUD7G&C2C85-6Y5.(YC M.9YVHT?Q0FC3Q)A+]K>4QA9OC-67Z-IBBBY;P%8FSN)M;UI&FR7PBZ M7T1^76-R%%X.EE[RI5_N96'BE6 .)@!PU6'&I.BEFL,<9\6PI5,40%1ZYZO1 MP ,\6I2U61WJ'+7UW-\9)3QB)-']VJM9F;=!0 !@W>1A&>>%96G2 'S"' 18 M&G":Y@;Z'$*F9ONY8PT40 "X6PPPP,U1X0L,@!7J)):EYP-DGSVF)>,-@.-= MV?#1IWVNWH(>A>5I7"L&J';FV#/6EF-M%7,ZU33RY6'^)4(HP%219&)&YZ8T MIP (1&%F8P90@ *0XS/ H"-$B9?4F-T$@!"B*.,.NE4 M$2D )$!3)0!"/*=3>2E"<&E356=BGES*96>*4@I]QF%2L)_!U5L-#!UEZEL- M:EM_"MMFOB7/:9O#O5[U1=O8^6'T(819DAN+79^?OAEJ/B7W,1M43!GZA6#' M11WG6=R_]1FF,AO7%>2<"L2@@N&F-EK:G6A'KNGY)*=@+6=? MPJ@ R"1?.M6L9@ !I.13'2E4"28 I"1?BF,"/*E3 2D%$,"3*H!,>J-?4FES MXBH!^*4 /&FMAFE*5NN2/BNO.I4"/&<"R&0&3*=4B6F-ENE+(J:XFESI29.K MOO]KI1"G9R$BO(;DBFI7BVK5B])H<[+D./(J!JQKF49K!G#CD/:J.48GE ;I MNI*KPN;J4Z7K7_YH2Q;L-2H F7HKP KLN$*5 +0DN5:5=8YKNHZLZ.F?/=6K MRB:(ZLGF9M'KRHX:2':82&+5OCKG4W&CN0J$P 9L5'&COS[5CTIL!B!KQA:M M-DZKT!)LQT;LPG;I-29 Q7:IJPCL!0BL J1DR$(5COHHNL+DF8Z>"#@8I,2L MV3K%FK46S)[M$LYLF-7L5=TL8$)MP4YM5/GLKUYCT![K4Q& 3!KMTNIJM"JI MTQ8NX>JLW4IM55TM5&5MF4K5D19FY'ZMNC:A"8S5H[#_K>8>Q0R,*&NM[>;& MJML.&MQ:E=R"J<$:ZU1!+-T>K)$*K.("[K%J8W3>+*Y6+-X>[L4>[3BJKE1M M;=&"K%21(YGV:&&:*<>>W J4;>C&;(PQW6>!;O.^%:P&EJPVY]Q:[%X&:U,I M@-TB9MZ6J;"FJ[BFJ^PN[+[V*-.&K0!D:W,"J^KR94IZ;U1]:YB6+^1>R_&6 M;-CBGP]D[O0&L "G:/7*U?72:LZ.+T),U9'RK/:BJT \*T*X;Y >K9+BZ 40 M+JZ2+)8^[0,7;95N[P(/[Y@6;OU., #L+]@FK^@9@:,,, S'<#,6,/66+OX! M[^,.)IDU0:/(L __,,O1L,C9_["I84#&%NOOZC"9:8 5, H0/S$4XY@0MY5> M_EB3=G!4X; 2@Q@';,&B1#$8AW%Z33%;5?$6GS%\H6RBB#$;MS%UD?'\$3$: MSS&(C2U2W3$>Y[%_0*,4:GO0E7VFM8E5Q4%\&[@,I<&3^Q@_N\CCS(IWW$D;P1>,:[I@BDFL[(F M<[(BNY<+ES(MUS)/G3)$X)603E709C)I^3(#PW)\[>T6\[ M'S,RLQ0N%P1> MN6Y4];(K_W(T!W./$;,2,W$R9[,V@]0RM^FZRKE9LLB)MD [I/ T1W\T2(>T2(\T29>T M29\T2J>T2J\T2[>T2[\T3,>T3,\T3=>T3=\T3NMSLBYKLQXUZS85 M4H\CF1( F1YI01MI6F\USI)U55/CK5+5SG;PIDAIU3*7!^P?@.@T7_>U7_\U M8 >V8 \V81>V81\V8ILT3\^63WNKZN9S[_)R2]ZLOSKN7W+_;.TNM;&J\MY" M-6'F++$:ZT&3*V B:\/2+:X2[ 58<%MWZ5I7\--"\V>'Z04 \PG+I$#+Z#7* M*-/B5@B0K7\DMG /-W$7MW$?-W(GMW(O=T8O-EI!HC5/M3JS=?;J[%V'+RBO M\X\^U4F*\V%&YT&G[L)JM3XK[>Q"54(O\&KWZFL?M)+*MG>GZY&R<->F,.5F M@#?*\T/K5@E@;G\P-X 'N( /.($7N($?^$H[=R,VMEC;K71+=G;3K>)656:C M=EN#:7,JZ?F6]^ 2["YS[=&ZMT&O-7RS,'X3[5/;MS^K<%6SV'3C ME@K\!X+?.([GN([O.(_W^$DK.'8Q_WADOV[W3O>$5_?%SKB%>[9V-[B1'F^Y M\JI6MZ^X?CB0UFY8JS)WH^YK)\!:'SF44Q7>>NN6!C2,BW!O-U/M[F; MOSF27O5*+GG&DB.O M6GDXYZKZ1I4 < MKSJKM[JKOWJ/U[DS2K)A@K-C4U6/UC;J*G"1_JS7#CH"MW@$RW,Z*SJ,;JVC MQW@X C0(SZBN"H0U9FR32NUKY_I"GRN.1K.63B[)3FUZJ_AN,0%_P#JYE[NY MGSNZ![:L)_^AD&_Q>H.5%F,5><>R5FF %.Q'NN>[ON\[O_<[1Z\[3IFQ2EJS MZ1ZQDK\RO7O511.%OS>\PS\\Q,?ZZ,HL(L>REPIS55WQP2-\PG=57C-\Q(>\ MR(\\R0LWP-]ENW>\RG?7;P]%R;\\S,>\S,?TR9N4P*\\SO.W?__$S/>\S_\\ MT._TQ)-\T>M6C0=%T"\]TS>]O]<\]UK,ZU$O4 MS4,6)5,]16-\(J]VB-XUQ_4US]6V(L]\1J]N/O$VM\]WN>]<;?] M1U;\\O=N]WB\^XS=^7_-]1TF]9 '^L1/_?H_Q=EUA M/F*2O2)O@!?SA..'ONB/?DM#_DFE_*94+(Z&*_<>/N:GMZ%C,43/\Z;,N#N' M+3EB[#CG+ KO[T0CID#[\Y?.?I%V+9GK?K?.]>9K:4-[K5B_9$5+8@?HM4Z0 MOO5?/_9WM.G#E)#'MSC6MT-O/CIK8WJ?*>67^J:L^'4OZ;50] 3_ZJASL'W/ MM4R6?\*ZBO"G/_"'?YCBOY9&/T!0 #!P(($,&0@0)*C@8$.'#R%&E#B18D6+ M%$&LX;218T>/'L&$%#F29$F3)U&F5+F294N7+V'&E#F39DV;-W'FU+F39T^? M/X$&!?.1*$<;1Y$F5;J4:5.G3Z$Z+7KQ_V " *J DB0P2K6# H&4OBJ]2"& M@1@>7AAX,"'#AV8!H$4(P& &N&(=@@704 !9O1<@WCW8UVO!LF'MGDV[-G'< MP60S]!7[-R)LUB+\P4P&;+E@PH5MPVL. /UL5L=)C^H%BM8 MT ZY-Q18& #@#.&SXH7NV'EUQQD$;O4NL?W\QG+7HY4._VII__\!C"B%W8K* MS< #$4Q0P049;-#!!T,BL*/@**S00AN&NZ@SZ.;"*[+EKCLL+N>?*VVX] !0@43$4US/(ONG> PL[RW1T3+OQ DQ22=)< MD! D"*&,4LHIJ:S2RBMED3C*(?GR+.B%%5+,_KJ(#<<8E(8UT(B*T M7 W+2S'-5---.>U4-RV]#%74#"V"2R&QU%H/U1LQ,%4A_=R$J*^S4E7HNX9N M/*C0[-8CSSQ&%<+*58+DFC6NS%X=ZU:'C,4 T?N&;10O)"6MUMH,EJC4TVVY M[=;;;\%EK5)1R>62U(N,K?$\@A(8E+^P%*M5@;Y@=6NS]Q2R%Z(-0=O_E=>K M!*IKH%_?-6S=@>9]KU:TAM45SQB)?=8Y>>GML,Q%K\U820VDT#+21 M/1VWW).#.U=)=S76^ )[^UJQY9EIKEG2#;9PDN2=>>[9YY]C,QGEH:-2.4F6 M;8X466*3;MKIIR_JX P)@:[:ZJNQSIHDH8GNFBFC T0:Z@ Y'-OLLY_.B$"M MV6[;[;<[Y=KKN8\"&^V[\_<["93JUSTT4DO?2A0,:=;<\]9;]WU:BDMT/39 M::\]Z\M3/WGUB020"UW?&>]]9N$ID+DRKY1,_\##BY2/J/F'G@<0 ^3/SI8H MV['/7GN0<<^=W-TE$OYUM(DW/C#J XR>^>4;4K\J]DN;/N^./]K>_OOQO[1[ M[T,%7U>8@3>^K^B+9N6+" 'ZA#X N:\B#.0*_!PX&OGA30,Y>U+^,)A!#2)H M?_SKDO\&R)< CD\!!!P>6HIWP 1"*H(2<2 #6QB:">*- U/KR 9QF$,=NJ:# M'KP0^%PEEM[-2E^S @WQ%& 5]B7@ A5#5I_8=1X"F.I7IM+7AI8F1#5]1P" M>:)$].(F4R'/@ Y96JMZ1Y ^$2 ^CWD8FQRC/#9])XPKBAY!B@=!XRSD.0Y) M $.L6!:O( M^A_LX2/ M^1"20#EI9GHK>F42X7,K7>+EC[I"GB[?-QAFAG),ZH&36.Z(2[:(17YFH0@! M5B0 MP@ -.H*T A08ZDJY4 "(3' %,# SJ!,P0 VX4$[)9 #,-23)>]L$#UI MXL^7R#,F LT40&G2@"D@-)_[M!)!,TC)2J8,3*&1960\A,D+R,PKQ%M65>RE MR3(Q1'PV,J-\/(0!'YGOHL*3I0+$(E+X$/"6$KE 7QG<[]>9V./K_ M2^BMZ*9]9!9@FE=4ONCQ*RFU95TVVM2&J-0NPE+@G[[S4U3V,DD:.($C:3(% M .AS)#P #Q=XT^(,HB?(KEG/]&Z((0^R*"86BM,09 MUC.*C)[\'*LK;(J% OJ"(3:A@].J(#6V5;W81R_*%EH2%E(M4.=,S$H2 / M-FIM9X-DH%>2*-0DR15)76OBW)3PH $OF:N#H&L@ ,1$NC+9+DJ8"Z'OPH:Z M42IO4/X*V-X(5H2\;6U$/!M:OE#$3:DMZF2A1S"N_T:F6&KZ9$7>>R*%X12% MP-RI;>4[PP!'!"S1%*04'P+3!\[4CTS%;V(ORQ7](MA&^LTM0G9;)F#^9PB< MN(D,C@L&"2CW-<;%KDGN&I+N9G=!6,)AU(&U=*W0/+9(&*/J=!'4Q2?(J@;&"0:P#83$8&D 0XG8: ,H%:'?% M&A)-#\0D26YH2(Y,ZDV_T_\ GAY)K0& 8Y*06@*RUB>I^8EK !QWU3Z60:-U MO&B%BCHD4VA #H:]3WCF]=BL'HE"XGG<[>*:Q2%R_^VIERY@@)0$RO=4MDB.'Q-[I=C:CAPOK MD:RX) C',;I3[.Y0YUK5!*FGI<% D$\+6P(IQK6NZZEQ=Q(DQ2&A+JF#'$^2 M*UPD*Z8GHZMK;TK#^[D9M_4^5\YDU#G92U .IZ _B9V7^7+0&+X8G-ABTIL. MDV&.4D K"3AH\:E4,_Q!^KZ^@V966%$X.7L@_FP&:1.V!0ZQ8%+ NV2$[S> D?KL]WYZ8Q?_M?UG*MS46SR>8.AN_I^_$@HZ>NKI/.#T]/NT&*%<&.!9KRK,-Z_ :@/BT M5VYV9R_CY_.3G=1_>%LE$.]U,_3QPQ?X2:"-X^"R>]PBD>?M-3]>AJ[[]"V7 M]*@;(/Y\KWO@BD<]]N/=?1:/U]*Z3CBHC\NLC@OS2.^X#,#_@FS)W&K2FNW_ M4NS?]&V[Z"G>.D[5E(L 7>\ !2X!=4WGG(3G^J>BPL1-_Z0LG-2(Z$9,?9!% M8)CFIFJEBA2"64Z044BJIV1F!5V(C^!H[U P?,JCSYJGSSYD8,9B(+ #[1S& M"+UN",6LFD2D3KZ">ESEP6KEJ@S)4?B+MY0$=$P,)X[MT]J/X1X-W,@OVZ2K MH2(O^3!-UV1@^ZK+]6+/#MX1IQ\O](3Z]RL9UL:# 2_ M1@3'Y\T$:!S),318X!' "B>.[,C>:@S]#9[<#:&HSP EKR0@JMAH[@X7#CJJ M"Z&&S-G*#3J03\7630]IL0_C2IX*KM]VS=J4$=8(PA ;4""O$>!(8LG*Z[HN MK?Q&CZ#64> BLOQ*0B%PS*!\;+L4L T),MS:;?O:ZA1!#?GN$ T9[_).$19; M4A:94>2NZ]7\J?TX;1M34I]&\26#4=J"T1H5 M*1K++\;_[G$@56P@]?$5=:^>5!(@4Z+TV$\O9RPAX9(03Z+4E%<.J\SDLP M7\\O&ZX#,Y+2ZA$2.U+;>-$QH1*Z/',93?+:EC$.5](BB_+[3.+(_,F?4&T= M9_$34;,P,:VM:I$5I2_9)!,J33,U03$-%P\01T(A%9,K W ;>1/R;)/X9N\O MHW(3ATP0$3,YN7'GPM*2QM)URA(MN7,<2V MV9(FCBP,]0JB0O,5@>RXDNO5 MTA O4\P5"U N"7&N@$R@8/(Y3U,V,0TADQ(Y48+ZF-/\C \8_2WE%I$9AU.O M-#(SRX\2@]/PPNT-62P'2I(,NXM"F_(D05$8]>U \W.N1F_1_W81*N>OY;9Q M-V\QR&)Q0U.TY104-]D-/C>/%V]-%%VRYA[4.(E1Q8S1/W4T*%NM$?7J]!@N M1DVMK;"RNKSR1U&T)\#R.NLF.[MS2JF424 M\B2-]^"TW.!I0>L4*._494+H\,4TTTX#HU\>CQ*"M0Y0PP3YN2 MH))-V8QO%U5534%M1*]2US*15Y'R0?]_=2>>%$I!J$JE=5J3AI&N1TMW$@ 4 MK>"<#4Q)S\<,(,7:TU1+3M9NC=G,=4?9M.)N3CYI-;Q*0M/TZD=Q;B#T4B'B M2EY53.-T+?S8E5BYE5 13D4Q,U$%REP]TN:(M=B*KRE;CE\SE#3Y;2!*;M7J MB5.)L=/P,*_,[2%QK>/T">&56%%[/U=-8E4XC$24*[N%R[D/;2F.!LTXG M[MD\CMF6M4[]M:R #&?KM=0F5->.%3^%+K\P.A%#L_@EJ=]FG-!@1L MJ'XP:-ZLL5.\DB?N,U,TT2:BL^%&5B94]3JC%6K=]FU+ M@P.\('0PR!K_0W13LG8GMO92FC4G3!9'U1%!>JT!>2)O%S-3UC8LV]9FJ@YJ MA-!I8NCK:B9RQY$#+$AV^HI3#!=;N:7(HJ36TK8V%K(G-O=<0W=*$M<;%[=F M&A=NX8XB'G=F*'=\-. *_"9S<3=W,S=U07!U::9U:X;,SB9R8]=VH7=\R5=[I-?) M0"A=\$(M""",O(@Z9.1?L# N,@M8W@..VJ>)EH.+: LQSFB&ZBA_.^.C&B-6 M5.H%C3I$G)+)R[;#*T;)ER",*[B7+4!K7M2N*@ZL M?2/"E;B) *"JZMJN7>"' E9) +SB M:WG/X$>=XC.U[XL=2.F?1.Z&RXI!2G M"#Q&A,5XC >'A %K=:4C50")",&"/" "T#3#G.2GZZAGLIJ)JR1,IS@)M%JW MSNSES?+8+@SBIW@XAZ5I7WZ%B8=XAT%,/&@JJS0C>8E*MO*7*S8K;THLC%FC M:VNB;VD#)CG9)8I,WT FE&?"DV7"E%E4-E!YD[WU/U^Y=LQXHBX).K8B592# MFP9&+5B*@#2I=4O++:(%J9P*D9*0"(.)"O]W:;6F2H$B"T: D+5<"WZD$'DV MI.J0&#IBR9?1PGN;N8!/4'F?A@MUIC5465- .99S@I0_YIQAHI5AXISWEFW< MN7)FN9+\1TP8Y98QQET2(@&L8L,^[))I4$[#FJZ%;> MZWC5IX2>IW&W"K\FJ(^)^9LCS(2BV9 Q"I'% RL<.4>JJ(*:13:LZ< M,''4\J2[T"=4&F3_6+IP7?IT;R.FSQ8EYKHG;#J>H/2B? MUZ.H<]F!O[?O!@.&D7@R..GLK-G!_ R)S0,LS.-Y)LB'@1BS']?N= 7OZEA/ MY.[MPII%A*7J$J*]K"[I7-CO)/JB$:Q=6 2S\\8$P%.3V[)C?4W:N.UD04ZL MPI7%CBU?<\ ?"8*L"HZPMZU=Q4T1^]'B+$_D1/*Y!3'E&/#;Y(GC"'+5_-/9 MH,T :>Y?J_*>SOM?RRHBY>WU<@[B2B*X::U=Z]4_,VW32.U(GZMCWUOE[-6M MS(W&)FY=SPJ[]_7>V%O5$@T =* #(ZW8'A5?/^]E)6Z]>1;EUO3FR#O:_P0* MX10-X>@IL$L'L?D'A+"(+&2$9?3BFRCX.<)([Z(H@V/%?2"[@(WX5_KB @!X MQFT[=J?PZZ*'B!P(628(61I,1"X&@W7JQ6_KQY\IL\2Y9JX4KE'Z)=CT^#QV M^8(, PU0(F^Q2#\1H&Q1]"QO))>O^?X0HOXM^IX1(I^+*A?M)2VT#Q\O*X_3 M1,E*S%GR 5L/+KC<4-TINQK XY3+(9EO95&OT%5-H#X\WE0S)BU25E$1%;N<$,>TW-*4\]CM M3A&/X+[+2PU;ZB7*MK(=86===3&RN.ZQO\^K4]G;-V$=LO;O+LT!>'D?1BL_L( MED4C_!<1-!C'%DC+_"=E4J\$'G]Z/7=^O2*:9=A%?G,^8&JMW": DI_Z>BFA MHRE5MNXWW,1Q0RJ\N?0O.\W+(U5V(NQ\TN M2],W*9/@%)/?6O3]FO3I$;TT][W>JSXQ52(OYSO8Z"_50Q3L!W&YR%ZGOQ5( MXW4/ZY+8'K#+'Q[N31\_]PWL_Q0I[WXO'9_CK7-I TM*!S_[I]5R#Q_QQ3;9 MI9T_@W-)P>UB"]%7YPT@>5JX+E%"!?2YE#UHNUWMD7+]T9.OUM.YCTLRE_]/ M#7?( **!## $P1@@"*"@0@!3%!(\Z)#@E 8%$RHTP"-BCH$/&Q+,(0$,#XH1 M_Q6"+"B#H\(I!T<6G&+18,$&&1VF?,G0H4N<"&N"F>AP(YB8"B7D4)C2*,*+ M-2749+F4*1BE$B$JY$%4Z$V'4 L::$BSZ,"M/W.6/(LVK=JU;-NZ?0N7D]RY M=.MRLH$WK]Z]?/OZ_0LX\%^[+%C!L[?@PYLN3)E"M;OHPYL^;- MAC5@(0PZ-">X)0$<+5OS9,>"J@V$%,GQ*](&KXIIW]:??G=-4$>8VL*!%.]Z6L) M5DG*(+HZXG895B5,9UU;]L?7XG,'K0W3:3)D!!5,,_\YYU%T!)$$DT?L>:00 M;5YQU)Q71PVXX$#LS40051(UX%Q-[S5U6E?T%61?A]UM5]!(#.84H&X$AM<0 M5@E:U&"'^I'&8X\^_@CD6:+9)1A@!P! @PU')EEDDT[F!1IG4DY)99567HEE MEE)J$,607LX5Y%#-F=4A /MJ)I!8]:THT@ ^+0A;E@UE]V8]RTUIDH2Y/F; M@2CRB=![S:FD7V_-W:D;4?V!D69O%'G((FX7K0F&H "\1A.(Q_TY*&MV2E2A M1IM:6EM$>YX)89H&4/K?2F/B")&A9L8$DT6R]KEFFP3:S_EC6FI/'-"]=?+W:7 Q^L!)M=,,ULOPUWPSK'37?//^M% M0]![Y3WF W@93732'R]=6=A80IU9UO4JOO767S]FN,A#D%UVW99?CGGFFF_. M>><^__.[5PP ,, 7WV-J#+C@@A/^F (*'!:YE(PCCEG4EC$N&>[XNM[X88\[ M%GMBNE/9 N65>XY\\LHOSWSSSK-U=UZBD_[7 P"\T&Z2':L^.&&4\6Y8\)O- M;OME %PV_&/IUPM^[[\W)OYAZV]6O/%#/H]__OKOSW__"D>/%[Z5#F-^2QWW MNF<7R6#@513@&M2:\SK#++ YY8O:F"*(& J\"@-0FR M";!"RHF 6.*VN.: M!@ 3CHD"&AR3TQ*C@#%=S3!9$T!S"."[%1JFA1_=Y@E J"#AB%AEG*&K)PA8A98R+ 9 M,Y.XHZ0E+V,"-*91-'"LIC6OB@DA1A1P[0/F9ZDX2'QJ4_)C& - MTU2C-E\*TYC*=*8%X>;?7A4#T37G!>',GD_+:-;D8\@FQ@66%S%3#1T_#3*VO>15M2N]93X!^[O!J[:, 4NDZ0G\V]97QE"IX@^=;O)K7H 0M8U/K MFMK$O,^AC\/=177+6XN*U:"YM6QB#/,(_FFYUJPO(QOP.P%?S+B._N]W%O'*,XVW@ G]YW"F>M[*[A.2(07D8 M4U9RF&UM<=6<&6*#^C6"4XO@AIUFRQU*\JVYY=H,+Q!!#G?QR 10*DF=VC4$ MQQ"$(SZQ2%.\& YLP<$/IK"7OPQF"EOXPH[-<&-(^#HE._6"(,;L8FQX 816 M^56,^:Q>M=A4.!-8AO*+(6#QG$/ 8E$!>;X@!M%\YQ*"%[1O'O\3"-6\9JO> M-9+-2:73/$@ W.GYB)+10!:XW.4PBWK4I);IF,D,5#/W;M6L;G6K-2 %4(>Z MU+2NM:W[=VH;3(][NRY2K_6"+NQ95ZBN+K:QCTTR)\AZUK=NMK.?O3DYTA%C M#/AUTJP-&&S;(-A[436ROPWN<%LF9YTOTW:X*SVZ'C];E_'&]C7 MZ_9UQ8WO?.M[,44H-[/5#?" "[Q@-LT;'O&B;8\EO"_:YO:PZ[+OB$LB+W&UZLUQSJ]1KF W X ME.X]\9SK?&OULWAH-@[TH N=8J ;X,?_43ZF<3;G 4A_][0!< "08RQ)Z'I5 MU'?-4XP)^^;$WKG7OXXO%_C\WT,ON]G3W?&C-V>T"Q,O: M=ZU'N]?[X72YUXL9,^G(6M6IZIP,0AGS=WL%GC*)Y\SA[W7&L5_\[)2O/+33 M+KUX<[MC(G^5U*$.W>.^?+R/?*?V[OJ\6F]G MV:=4]N\5<>UAN%N3^?=PW4],[#>S4MY/'OCL;W^$A1]ZY6.O8TWWV].1U&MN M5WU,5W]WUE^U_W6JAW-9@GV+5AGC=QFXMUF!%'XE@X!6HH ?124A,%CJUWON MAX$9Z%SPEW_%1T[>-$>G$W_;MG?[)W/Q!G-0MW=OE$]:]$DO2&)U1H.71$:4]D7A U@.E$*$1TH]!%:7=$)3 M!$&'X4&V U8 <#4OMD$P"(2,X6=-4T$N%&E->&.59AG)98'KIX%MZ(;9E&NH M=D"K)T3RE$\/E4FMU$5ZB$F^TV0[]%"J5&3^Y8.9)EJ91%Q:,WM\F !\Z$R_ MA$'/M$Z;U$N-J(B#=&E#1HF,=$B)Q&.5>$E(%$**:(AM=7ZR16*V<_\!E^1? MF91*C%1DCL$!RK6&/_>&MXB+U12'$B3%^>HA:,"A2/#96'=5%D1B)6M-/LX5*#]6,[.1AP2A/PA.$ MY9=)S*10#<@86E:+;)B+\TB/<51TO$AFOGB((B1G8%1&!9ACC):%52B-S=B/ M^UB%CY==,<99& -)X!-7DF0X+X8[7455B_8JXLB0\25%!_E?QU0^3RA7*J:$ M8=5IGQ:/MEB/*\F2RK.+^(@T^HB*"G:0"]E%WT>2;B:0D$&()E9B55,^P-A] M-DEX"0:-^*48$ZE.%>F-%QEB3V99/9E" 9/NJTCE)D&;"6DO+8 MDF$IEG#SDC#I,?IH7Z]SD-.(D^5#9%.Y&%)YD&E9E>UD4 U47DCY@)=%D9]D MD8P68MT%2>E5E.2(0QXIC#L4-?YECJWUC)2A;%^IDF-)F95I-_=HEF4V@(C' M8VA5ER/&A[S4EK>$6S?V0MLWC!MYD/?58W4).[_T3%:V3B"T84>69/34E_)T M0I/E89,TF*$4BD;80XAYC/(3-8U)2MJE0:<9&>0FF1=HF=$IG2U3EA[31]2E MCUQC:)^I3F#U0S@Y03JI5SR$FG+YD]H)06I9?NCYG2&4@UWDF>C92$IYCJFU MF^ %5;R40SC$A63(_YVNY4*Q=4&9%)YG.'B1E&+]]IR3.9T-ZJ &PTUT5$[7 MJ9G69WL7BJ&147$+"IT/ZJ$?"BX1"@ 32DX8MID9BJ(IV@,<"I8@ZJ(OJA8B M2J*!4Z$MF*(W>J,]QZ*$ :,]ZJ,QBIDA>#'-<7!KIWP:DX+"QB[_1SWEE)TX M"J7XIGL[RJ _:J4^*J-Z@3%XY'!W9 ,I2'U+XDW)YT=/&J5G>FQ32J4=>J5M M^J)9BA<\13U+(CK]9W_NLFMT"GK8>:)HZJ?@EGYKRJ9N2J@/"J=?"DX:(Z'6 MHS'@%'7LDH)D.H=]^J>5ZFHB4(&":A>%RJD>>JARFA=11X(O< '1T=,PO]T M/R6DJ4:IENJJ6Z.&FCJHG4JK8RFB8X)'&".J=8J"&--V-.!-'U>FK?JJQ2HR M'4"+LLJCMDDV]JMZ:NX1JO_>I^\TJO@8&N M^$JPDA&9^[JL_JJP&0BP ?M8%EJP$;L93("P[[JP%UMY#>NP?3&P$NNQAV$$ M%6NQ&$NR0Z>Q&UM]-OJQ*TL9&RJRFUJR,7MV)XNR+-AW+(NSD;&B+\NO,NNS M D>S-6L#'9NSZJJC/%L7/ZNT&Q>T-4NT1[.H)KN(>+N(FKN(O+N(T;I(0;5(XKN9-+N95KN9>+ MN6@+N0B4N9WKN9\+NJ$KNHN[N9Q[LUR;LRK MJ(VLB0K!Y0PNK$+&J5[EO:* MNNIZ!&O+NE6+L6%@"*MK=L9#N_"RM;>+IAJP96:[NPEKM63PNF<[LY0SO)%[ MNL;+LB @",H;9JTKLV3 "-I;=L([O>=JN];;K2L OE_&O3Y[!V4;O60SON0+ ML>8KL4G@OMO+NS[;!M\K_[;OJS+QVR3%2[]1BKQDN[PP>[41$09]T+_!*[T M+!@"/,!0&@+9V\!@MKY+VP:P^[7^F[4;*\$3C*-'2[4'G+0)?!9AL, =[,#P M"\$"6[XB;*S.R<(8G+]7^P8<_+(>_+@OG++5*\,>JP%=$+8F3!TL4@$\-@_*K[,L8V7,9FC!9XH,8M_+]MS!=0#,<9N@%>,,?J>\-FK,+\ MJZQK/"1\W,=O_,>6.@*[)[)5+!=V_!9XG,AZ_,$.Z\>/C*%B/,EDC,"6G,1O M@/_(:ZK(HL'(/SP7GLRR3[#$HGS"9P$4/U++; $MXY++X8(5B!(1V8(0N^PR M:(,BWU(PM[$6PHS,;['"@IK*@[O*-MO*KORQ#+;#LGS$U/(J,G#+/=+-^N,V M+@,1P,P69'$6RVPPZ(P6POPC.8S*FMS#;=S)U&Q[)"#)[DK)HW$5 .++;O'- M^=//OSS.[&P3QOP0Q;PPZGP6!.TC81 (5/K,LQO- CB_]'RO/Q#*=#S*(L'/ M0/+/^,/0"S'0;:'0,M$A!OTO)1T1(>TC6;R@$4T8$TW17VS1!0L%6HS-5MPB M_*PIPM(<:\,H8Y(#M8PM'"$K#0$1M$$GGG(H*J$;EG+_&DYQ'%:Q*N1"$%D]'LTB 9;B$=L"(5[Q$A0Q!>S1U8F2+CA$PEQ&VD])FN-+&E1"!P*TT0BT_--'@$-!G+PTCC3UQFATC^RW22-TN,BOA.-V(GM=24PM?B,LX+HMTCSB$[, $"GA8J M/-A?J18G$B&D/2[9S3;=':(/+-Z.3-Y^&@3[FL\ZT=$?0>"O M]<01')?>%3 M82:R#=P48>&,PM_=,3 0[M;ZW2(8$QO&'2%MC>"S32D,;A.7+>,KC= ';2G- M8,[UR7@VN/K_2'[C1YIT2;R?>!(X=ZRG>:5TAWF7"DJ\>$^ M<1!I@O_?:,'F)WWDN0P3_&'<7FX23FWDNCWFS'W98AXMFP[D4B[B<6TJH@[9 MJC'H+7'BMY[$8= &C1"/;!$3Q"PN@VXSA?X_-I[H.+[H9]H!C)W)CIW-.XWG M6O$:.6#,.9#9L)TA19'I]QW<.)+D2.';=&[2SS$34>W9;;W9Y7[?58XQ&>'J M"X';J!X1; [G".$@_X[<<*WF \$#Q9T1];T>OOX0R1+L8" &", FU.T088#) M%L@6S@WE6^WDL_[I'[$I0R'ES@[AQ\'67I'5=PWA9!$6PT(PV!(2?MT<@%WS M88+HJZSHU9YS)^#HZ:W/W![IN8[DH>+5O$+4'O\I[X[BV.+_X$\MU/Y^WU7] MV61=U!%Q]9K.[MDR(D,QTK],UE+/[H_B\-L"XV)B)@8OZ<#RTVP2]@&O(P@= M\&(@!D)M\1?_!I# "97 >VTA$+]1[^@Q$ Z.SCMA%+Q-]B5OS,OMVZH=(])\3>^$&2\XR\\SP_<2[[SMJNTYE#Y2AQ^4#GZ6=!]T(/ M%PM<"7P_=FTAVKI^T(1OS!;Q%9.M(22NSE3AX /R]![>^\,M%.]MZ_^](!\O M(YPO[3I/[: ?I5<@JX]N.;51X)Q^=KIR%E4P[,?-(WH>!Y-0">?M;V[QWEK. M_+:_ZP[DV=/G3Z!!A?ZD.=3HT9\- "R=DE-&#J11I4ZE6E6J# R M@KJIL10 5*ECQ@0B=-,LSJ &"$K@05!M#JT"&[0E")=' S Y)$Q1"X:MW[9_ MU]+- 7:@7H)3).04;("O7)]] 0]\:]@JF+,++V[FW-DSQ)DN+Q!XZ9' !94 M2J<\O1HD!0 "7,^F[1I%9MRY,U[FW=LWT9F_A0\G7MSX\9]B?;NAI!NW4,E@ M> 8V$ KC_^^T^D.G&)=*U_$D_\*'D@>0%._ @U8;@!V\60P#23$E?$^Q_;J MZ,GW/2_P/57G./EL0 (+M"$TDF#SRJL+1J.MM=HBE' C 3"8\$(,12HB0 [- M0NY#$'#*85P%EFE46MWZ4^O?"$7-OD=6&#@NNM.X:C6K4@&6B,F+JH M[N(3 #^I,B ,D-D28^2AQ")Y)SP2CGAEWWP%]N7.A"6)V&0)N/8"-*<]=^". M%/ V6M2F'?A+"PF(EZ-LC=XH 6@S@.U<,#OBM%-X*;P6Z(VJYDAG"GGF*(&K M"6B:7)#T]8K9:1=3"4UJ!,9CRG,-YP9-2]*Y?*99@SKTCFD6AV-^H,*LP@ 9XO:'IK MT.U%+8&COX464VS=/IUL,KF6&@!DW;T6=XY:2P#NI4L_?2.RD;:P>)&XA3;M MILU5D$+>XY90@RSH#M#R5%%E@Q^YU%*AO,(QD2CJO$*HZ\A,(5J:C).[0;S$&)-S^EB(9_^$E M?^\)X,9RP*.U+.@^'%/*^O*R(+H0KH,(W-A2)! &"73E?V P'WKZTAX U - M0 E#'TB%/1P&!?]SFN,A:+IT$L]9"FMF6\KPW&5$K(EN:[N+7NR^!3PP_2QU M_?(6V4#7&@+DSEYJ,^*V/$(Z*C9+;:1)&[+NQ:]E3>MJTHO0!T1EO=SDD%%S MP@Z?%C,D*JT/?#Z:C-[ZMS\7Y@5P"01A?(CT/A-23&U0\=\# ?B>^T$E?QCC M7R.G,$F,N45M6AD?"<&@-OAU\I,+0M*"GK*@Q:A-+8C,H/P0^;]).E"#.>D+ M"@7 )R6=3SWJZ1A0WM <%\E1F#S980^-R3F1!'&-6-3B1TR7+]0HD7AK%$#S MW 9%"GEDBLBS8D>8:9IF>L2+'0$C\C@"KFNADV!1.^/2 $ <+6.C;7_40$< MXSC,.\V)/'AYBM^^1Z/QM,6/;Z&1#'A01Y]@!2I*B4LD]T$40I3>%?C3S(([HHQ3),*ER>HI03DCII@0W\X'LV2A##":ZENE2H/(W6I;',!(L:%N0A!ZCU#"8^&2J0(II3!XB,R3*].;JY.D1 MV_7.JCTS8A:=J !L8BU9VVSB,YVHNM$!;W17E9H4C_OL'0#XI2P! MP'6>M$&"/3/35#C-J8-/(@_X]B@>@2)0+>-;BD!EFIA-&A(]@WT204 YEXL. M:947=>@DV])1H'Y2,DRRF$(I0QW3*A(L3%HI_U@8V]C^+2B7&'NMC@P7(Y;: M#W]J^VQ?6!M4/N[RM4;=Y5% !H9?<@BP3'TJ5#,G59!05:N?&U@"PIF G[5& M:&,M&O%XEZVPTJQ@6!7 U0 PL"L&36MCK>YUPS8VO8)KC'3=(MSTI=:]TD8# M6_"KAY9K(GTBM8"&J9@@JP.D@>;%,@6!:%_NIY678A0L/ !<1 O( XIZ=+/\ M^/A0&N (<",ESI!D1&_N]EFNOI==OA4NL:1MO MZ!B4M6M6BR/.RBKQ*O]T-J15%6GMNG)(YF77K6'YS; A8Y?;N1$%A3._LP&! M(/K[HB:3B([E^P[&AG2=[.BO,4%NDI\>8]G(1OB5@!MN;$G)0E!ND+(!)6D8VM9!5FXMEN12\4):E21JE5_!R6U)G1;>:+N2/+ZI1_6R'/_HI+I.% M C(Y /,Y@<[ADZ'\*RGO>3;F#*.R2Y,N9T]H!7]&"[$_I#VOT.5]\ZGHC>## MT#]BVDKCP]'[2"M90CYVQ:@>"/U\2[^?/M" G"Y(!]O2/2;[S[4JABG].,EO M_X70ISI>=;9Q'#]9[SC>1YJWK7MYTBF)^Z/%KS_ M2/TPVK.Y@'VORNR1F\1L7DNY:Y) ;8=9&SEXZ\EA+#*P9]*+[UJ9RC]!XFV^J3IWSE/Q("/VL=(68WCM=W G;LB9UA M^>-\G,*0LIO\Y(+]KL[WFF1HQ?*R@(5N-R??TT\FH0?V.KEH#I1DG\5(P#V, M=*F2"HQ0'MPQHW.A.%(^#GD#2=[RTZ=^RUN@^[X/T-;G_IX ML7N;0AK<'_LH01E0DN[()"[4ML5 J"GX#@3:HP;XPJ$H0S/D##1\"344"3;D M03RKPY*00SOL,@3L ]QDAKCQ!)C,+_+$0ZBC/\HQ?[[(-@"0/IHH"M\10*,14B919>H MQ9"XQ:8;I]K@10GY'>^RQ\IK@CTLQAHDQN-H1KM)1MY 2,; $404E6L;B(O)/_:!*/"8I'N\BDR\B06XA)62;4,!TR0YVE&(VA M0;,C>IO8"4G<@;/304L+<3,]\Y0\I+:5=+PC5(S["8R\ZYZF(+S# M0\:'*"V1EW$0"X 9.H__$BJBPO[T(6[,Q% M_** :^$:KRR7,$NSKW2:IK$4LNP(7GP77U3++<+*SZ$6^4R=_)Q+4(H>4'I+ M4)I#3?D!O_Q+H9B3(7&MVYL[R_I$Z<@.Y1.P/8(8_O,+PPLD!F./N(!$S 0@ M]^ D!%*T[!BZWON]%U.^U6JTMF@/N6@*S:1,0-JE\$ ,%HT/%\4P^@.@2,R] M_ZP3+]VP- MJFPBLA2BK.P(;]$6L?J<] 2S]<1')9HB7J0SD8C/I;Q/O%PC-ITZ.%NGYEDO MJ&$6!0F8MC%[RD MFO/*+P[X@O[J5:3;.C!L-7;#*#'$M1@$TDC%PEUJP4KS&\MHP1FL5.GP$[6( M#@K5->!J471L('4,GTE;5#NIM+_8+%."#Q##M0V,5?RX6$NSK8[) 1D2LD4! M&6%+4GO_A<"@!-9@.<"I(M;F%-/I\BJ/$**HJ1"J=-8V=!IIQ2^]DB)L!2\\ MFQW94,.1!!@ZE VT=$JGQ4MS,8TZ-MF>0% $RM$: M,3S[D]6U6+ )S4+^"T"=" ^!-=CUTYC\@XQ'U-0,;#JA. 5=E'753!93"Z4%5"@0M P=@[V=74$]MKPTB9_8PG7:-X+58J M72MG MTV5"*@#;,J(]IP(A-BF=;7O:OA,1J]BL]XX1:UC:M\ MN5H[@S-V.4IWY=IXW3,@\"O-%9%!1:!,S O\X+\2?5 J*30!_T-8O4F^3&HT M6M+0C9$+L&B 5\LH;@O%=@.23JS>/4+?BN6C&H4DA@PW[U4/BXQ?QLW>3+(. M2>0I]Z X12-2&3"99421-Q _M6O>KN/'*;.NT9=LI%J!FKEILG*+ G!@Y,X"M*1@?H/\W'(RJ0I=2.2S-Q, MCX(M61&@(X8@$_K;&0PN5K/<<'OB\HB.,&8+VNPW*^G?VU22[A&,W;RD 1Z9 M C:1"_RK5 '$J)C)./G5!L[!=S&=H_]LSJQ9%BOS"C3A66\ZF@Z>5G9YEFD5 MX2(:,Z\XJZVTUO7,LM,!UW!]NH\8R:UL&[344T\&B4=6 !RNTT?&SAV>JT+N M83;B )FPGB!NF."$D;U!V%KFC9/1DP-6LD%D3!#18Z3@X\!BX ;>C(WT% $M MB?=9:(YN2INFJNO"#(9FUVV9TP9A3Y9G#. M(9#Y97/N"<$@9M\H.GC.QDXDCHGV.'F>9^54B)93EI78RF8F"7ZV86K^Y^J3 M KI):().:);_M@H+7"J'IHN'92D5S*-$FDR)0RHJ+H@*NF(2\QL",@ ;L;N. M4KR\PZB+RB@=Z>D^S&B-=M('-FFIGNHRB0F5 >>5;FFM-BXP"#:%.6?_@(H7 MW1^Z<%]7U:5/PM#UL-_!K9$0Q9&!,CY$.\<$&M^VB-Y^PJ,*O>A[Q8VG=F!A MI6K!'NP)09A<46ENWFK%E@H6N2&')I*P9M06K9/#,JC*ME7I6.<=R=1VI@ST M$%Q%G=478U#(\*A0#<*8_6MZCFK";FW77HDA.&RL3NRAP$:KX&N>N&B(KNT0 M":B@F,A7[;DP\&K'SFT<$0S@!HS%]>G&&BY=ENC-IFCI5M@8%&T#_R/!]*W& MJO#CSJWGU_[NU[8"RIGM6SX*@]8)W%;&^2V.\S:*]#[;MI8YG!SOF*Y5R;;1 M4E6P3ENP5=7LYD-H]9-!M=6)BJ4_XU%;MC4Z(HDS 2,X0I,5G6&8) M(6+.Z"IIM'HV#:_J-_KJ@8[ !!? VUYOH1AQHPCP=S;QG4ANE0VT9[SJ^@YN M$C-K :O?^JU1 QBZB41?LHY8A45%P*G8Z+V/O%B@!47MW&#PB_!N\$:)"2>) MCE2)"Q_6# ^)*0>B#B\3PP;Q74:5$6]O^S9$%K\,%3^.]W9Q,68J6TDR&3?N M,93=?T:48:ZL-(3#7NC^3;S(KANUJ/ MXRONBZ> 33#VS6$"SK!=; !Q:B8_$-8.B4?/KVV_D"@7ITG7="JW=$PO=VA: M#4Y7$RSX]" &<\)HDE1<0;^ )(Q!DMNCO?T!G-7[(($2TD?[R1=[-_4--\(3 MV 25];PHJ4"G#+FVWH5EC!/U4/_X-Q<"DO'H&$B*MXJ?C!_-U M\&L/5H[&<+,AC7?_<4/3@4J[G/1*KDI]F=UN>>$B2OFOE*:Q+.2V21XT>Q?S MBG2>A[/3F/G>,FHSHJ'>*$US@!KM].NX5O6O >?LLEG<9!,"%0BI"'*C/ MUMO2)G!+M;]8EPY2_1%B!I_!9U5512!6E2-I#WF13W1K9_+/-3/CZ9SP[)JE MJ9>=!U,($9O-Q[-T^IGB@4-'MA#J3"LL-Z+3><]OE_3>^?QXF10UID0W;H:1J; 4]_-HDN;VBR;T3!_["Y M@!- VU;8$+QO&]7NZZ?1+US<6B?X;"SPX)[;#JWN=6N@;UXLPVC!@$)HI,;$ M]]=4DL6>-DB[ HW\ 23YDG<(@. D<*# # 8/(CQX@8!!# (. D@H\<)#@Q04 M('RH &-&"@@C8F!XD &#!$3.CRX,4-*E@PO9I28@8)(F3,3&#RY4B8%G 8) M<+SYTZ/!B@85>#RI4&D& 1@R)"!Z%.?"HD^/UDQ(X )4K@8OX.QI$6,"KQG MGLUZL"7$IP2DBK4I-^$1@G;OX@6C=R_?OG[_ @XL>##APH8/Z\4KD*\$'GIS MR-AKP#&8QF ,\ 6@%_/EO5,:@)&18Z^,R(PI@_]IX'BR7LN7IW ^O5=U9=2: M.^O]#$;WX\@-ILQ&G1OT9L^@)0 'G(.X;A[$]8(NO9='9,N-8?>58!IR:--@ MJ->>(@$Q^?+F]88)@TA>)76V7RD5 MEXLVQ3CCCC4>U."*'E79XU4- 2E2@U4B9.2Z\5X0DI+)2A1CE%R)FY:55GZP MQJX#'28=7\Z99T"KN3*$;J& M9W)]%4HRJ1@3!RFB>U6:<@.N\75Q9"Y3'*%PFY$](7.F]M^'/*N DN8G# MF,!.D-,H$=P N$6EX_\FI +6!3?ZG=2&\2#!;849<+*K.2Q\GIA0C# M_ENNI?M%)NR[G_<&)%@#3S#OPQ-_W]5B(Y]\@7C]2^1)&/A$P=F&Y\01!1XE M<%7;38TH(T<$).A3LQ(IM9.,;T%D_;(90:F 3R;Q3:+?E4]9>;\0CL12] ^E MRY5)7BWH*4%J'+LV-Z,%>25[Y?(1 J,DP,TEH"8$\/])X#;'.80DX6H%^]G! M1E<8U4A =H-)W:U85Y_7-4Q4IXI/"*#H\3VRT MUL.&_; OO+&5UY1G1".2;2Y$6I!3.&03>''H*0F0$$><(H (0>E(R#(1%KFE MD:!0@"D9B*)) I1B@H;[S@7#:PA8$5K#3>H1V;(O0GOF!GB-W)C*DDE!L. M36=509,9Q#"F%P[Y!C506^%@4,BPBT5(=8CA0=2V)J$@O@IW*!.A#6T8AECI M,)@\["6N<'FH6Q7QB,H,6Q+_&>E,9Q+NF=*<)C6K:,[, &,P,&WR3)))3IPH0TO@V&E-,S/-JEJSEQ9*3%1@(MIA7$G,?P(T MH,.K6C +.DR&:9)KQN088&CFNN,M,Z+!:J8VJQG-BF(THQK=*$<[:I,5>-,P MTHDAPK"3&5EN+)^DH=/I2%@9$0XJAA*+C0G[4M.:I@94EVSEPP3JTY\"U55R MH$1!#9JPAB5T:PM]64-W5IYD2C2J Z*H1_]UT:IB-:M:W:I'E4"K;VI*="J5 MC4U;=3J#G7*=FU%=*, MZ0#0.L% 5:JJ]0]5N>K:U\(VMK*5I@:Z,"NPO@9A."U:7V#)H4RA=4]J!>>A M*(E3$](29FO"*6UL9SR\!H:&4_L8PZ@;F*7R-;M]&2I@ SN84GWG-J9]S'&$ M4\^Z5N9.RQW/"]?*5-SPR;.[X2UL&^S@!T/8HR'H)GYPZYR2_I"5GODA;]":7.@D!Y_V%:N E?M2 MTJQ)EW35#GG\F3M>:M=+V(TQ7\-@B.X"=C":)-/I4A,:4?\-$3PBOHU#C39$ MS'SL-T/, 2][")J)(4=/PL7D\UQ:H"7< M[E>1T3)Q@C-J>FM//KBJR0&=,XZ"& M@;LX]FY@5"RQF]4,.'BZ%"J-5K1'28C/S\&,=*^3J#^=Z,G>L4P/?ZABWHRL MEI8.M99WU64N?YG,LIXUK66[A J+%-3/*2T +AFGO]1T:%(.;5Q/9]RWRK.S MHBK4>!B+-,*X>)2ZUTXO$+S4I74]88>=./ MCO22_^1!**^&DU0.I<28(TY2/73_RZ].<*PA+$;7PLW!=^-79?%#9:F)U\-QGG M0+SUYHL)SSM@1X$I-GQZU"D)#)IVHVRY(AMU MFOC;8^@ &.3R-?"/'T-MP*1VWQ+M]X,/7FN/#OQ?!8^MUV$K D*X1^;$1.&' M4[,I5DY&DR1E+S]=2L+U\I8[4]\3J#ACY5,N-U)^IWNF]/Z6,;R5C2DNWAJ8A@P[$A7YYI%LV8B"W-"PS]I>*M:QG'2/R8']] M5U=K7;5<_W=PV3LZ=C"'W4JW#^3ZM FYVK^V!VE?? U1Z%!.3S(R&J;9T6,C MG83RIF20GLYXF.\7<&.^^3";?IW&T\.G$S^@ZW'\X\,?_JS'7IFS;S#P-[I[ M".?^0.^/4N^S^?LP-Z$]YB<>"IU;'!KJ$M"HRHF\EV[H3JK=6YGTD&[03! Y MV6<0(-(M(&B4VOX%5!O<&/F5GP7*'/JE'Q(QS[^$40(@$N9PT4&$D05I MA81(!>90T2%)R%6=_$:4S=MLP(:DV5O><=]W5)\J75_-5(8L2>#!>)^\H6'QJ(<& M;ML@=B""?> RS=Z-/$48G4A%1 A15(A9S,4$E0M'9&%18 1-)$0:G45%-(OV M7$60?(A2B$M+*(!1"!)4B M0$!Q1@*( U 0 )-#^0,EP$4YC@O^@+0O(>_8U%3%@)Y8#B[YF%WL!$N>3$O'34#YRA/1(1H#V<:91& M9MTDH^C,>\V7[$"--X:79K1<3V*> TX>RO4DZ T-:I0>:>T4379)>HP?/=:C M5&87/N8C,X7@29Y()^K(&.WBAF! & VC1)C/O8C124P1W=P(XDB%O0C)47"( M5TPD]1P%]L0E0<+(C5B%"LY15C"ALM"+17 (421.%!*25N)WO*J$^])WSZRFG>B'U6H8U0(<%]B !HHE)L MCP+8)5D8A4A03D@8*7XF$%&H(BLRZ5YRC@#XQ 54T;K$16\N1(7:!/]"1A"_ M<"BRF(]J6H1TK@@ P>:97F?UI*EV;E40V,5AK"CI>!!YSN2-\JG6J&>- FJ@ M"NJ@XIB.@N!=7.F$0(B/BN5*AB7!>>$8*29$ F&4)"'ER,B'8"'XF,5\_B 8 M#N>#5N06_N63R* 1=N@7XJ!7$!+D5(B!SN 5.E&\X(B(!@493:9K10%!V.EI M^1:!+0>:((R(R=3BO6B?(JN7O %1$6JS.NNS0BM>&*KR[.,S+>K786NV:JM- MF "O?F?KM-=N<(8,H!O"4%*;J=VQ)NNZSL>?1NN[PFN\&N*T)D^U7M"L;FN^ MZNNL<:>WJBB'X!()%1B)N13X):)ELFO"SH?_HLEKPSKLP^H0O>IC5V)4K.[K MQ6(LA.VJOQ+&G592:'D8<4B'QS(+TQ.I_96%:;*UNB2S_9&V#,:;\,42IZN M[N V[_K""K-^+?MRS?-"KX!(KW5B5/5.$W%:R>[*#?=ZE/?&%O@F!/#Q+U=Q MP!D,'_S^&>HJ< .KA_MR;0-/C?S.+X#TVX9081=.XE)$R!%B8>\I9D0\H<5. M8>]I$4/L!!\9861J*;X&4A(V!19^B&+B)T!NZ*LV"/I,ZA3N8K=(R(/T!""% M*1@VT0;SHVJ"+R1VH1)280AKX19ME14LG 3_1?E2\16#01@L;]=B,:Y0N@+)F.4'!)1T.*Q<&_UB@1%Q$U16&)"]FX:AR(1*)!'D4OWJ4OENICAI%*8(N&]F9%+B/WJ/%/0"213H21/@_=&(6/]"<<[("QV,;:)O6AO*K?#$8+Y@8,\L+KF3O>SF5>DLB'Q$5+CB1T!G,,QXM'@**"YLN+2*(L>X2QP&)N M2L6"]&\AW_)6>4XGAS(HG[("DP'#$NTX>TDJJ[*7L3(V+_,:&62EVNHVXZ61 M,(GES(VN'__<$-3*3EOX6PCLSSM,A/ MD8J/%?D+A=F]\A%+NNS89)BON3B/\_+<:+@]*3E5LBEO\*JTY&+@.9 MB+XIY(#B/%,T1LX( %-+[QYSQ,;I6_G5U80QLSA:&6,\'\<).2:=U\\:C')0RRX[V M?*PU&+?UK;XI*,*//H.O_[CT3XXDD/;J]$Q?#X7"46Y*D$]5 (J>&7DK;LB=3*I-F8H+36F-!BQM1V,\V\/ER>D@(&FP3LJ=$'O' M][KB$&K_^%-1[CJ',:+R;I(K.39U !I $HK/%V4LRGQUC.61UR<1RG\!'F6L MT/]R?!;;RLYMX EIC*O/@361,_"0'V\8D++*JGF+%;F1KS*2+WF=V_D%78$& M>36/2QF9$*NAZ'C5M8:HM)#$C8EI#)E[S<9H#.S4JK:/O_FZFO/#%MJ-SO?\ M*NV=:WK9:[8\><>-Q+CJB%?AIM.)M<9H[%9-);JCKUMPH;=AB':DKR]* MR^M?%$H:9$T\/\?KL^CJPF[N^3ACP;-!LF(9+,8;L?)B[ MK]0]R4ZA]Y#NT%";J$X]P;I]S+JUK^^R.BRN2QP[F;?_?7A[+H'[\(A[G,LY M.]/YN4M\WVZ ;:D[E+^9J;1\HRV\?"1\?,0)UN+*S+_87^"\+^$!!$A//SH^)H"&:%K]NSM>3;A@Z8:&,U$S^93"ZG R>F>P)HANN81$-BQF-QYM4 MPL_)B%4&R(,);<1M XB3JA,'_W?0TM-T"E^4O=Z>?=KK?H2)=_#L%)BL;4276@!IF\R6-= M?_?YA:./#NZ8D$G%F93[QLGX#&D\C>T[_,/GOOS%,5J>Y;],D1O5/[&,X?QM ME #1 :! PD6S$#@@D&%"Q=>(, 08D2)$R.:>,0)8T:-&SEF!/,19$B1(TF6 M-'F29 X)*%FV=%FRHT>1$GB E)'C9S*R4(_7AS"@"Y. M+7M6)/]8M&_G'@4 )H>,CVK+ A9L8"X KGC!)%4+9BI'&Y,I5[9\&7-FS9LY M:XY)$;1"A!$5* A-$(. TP8=2AR]&G9LV;!;S[8-VP.:R%29]CZITG=PD%%' MTK0I8V[-C\E)-IC;&"<8"7/=.@>@]2P/Y'(%?[1^W2W:[7^](\^!E\=

X"C6(3&E81*K<4D3FD%>[ MNCKO+LOKER'@A6AW'2YLF#!/9XL?SXO,%B)@O8WS2L9&^:GE7HSI7@XM6EAE MQ: WTUQ,>EMGKW-WE8SZUN,MS6M3PXYE^K9@HKH3P^V-.R;*X$M#%D\>=S?< MV?]^3VN.V.QQS[RA?ZH];WIOYMHSDD2.5/EWU]ZQ/[\>-7;R\8??5XO_7_XD M_:_PN6.C>M]Z8/U;%=6??_8!.!1T HF7GW3''3/@>O\QR!X^$CH(5(7\&5A) M:'PI& R&=FE("8?B M45^".=>86X;I99'@K0DDE&*6":>;<;*II6TEKI>:7/;5YZ" !MJ> M20[U:6AU+RWJ9W=O&N,MK3I MC*,.U2JKIM[S*JP^KHICJG?..,NLTCP()XL'__'ZD;"[_C4LL< E25ZEYBF; M"UD(ON>;L_A >ZBTS9X9[985!DMIJ(YQNVU]U'FX[)QR7C3A7E)=:Z:=D"4E MHX7IJANNAZ<1>.]4[?%:[KSMXMI6OK+)^PZ] N>ZH;LV)MRFM@YO5&>D=#'< M*)UJUDHMQ4@A*^O&DY8*,<>66:QP=EUB_O.X?Q$&,&V%*^0R:Y^C M@RPWHWN^.=YF+RXY:/,B[?JM :?^[$^3;SZX:Z2+R[=MG-M-.V*G!U_R;;/C M%6WQN__=9>S+A][\W,^OCKI3T".O=_1-1\[X=,GG="WSO^M#7/BBN^7S\0M) M;SQOF F[K_O>XQA_]NUW7S\DF*%?[..Z>M]P"B,_Y-"O?'(+FB5\U5M>NH"RTJHX[[E]$V$& 3.!Z-C011VD&#] M",X&7=@Y\*U06H,3(JZ-0KBC8D^L>$-?">][.61AH_H2M[/!$&6!*Z.UQM.P-&XLBC@T M'>8TESL'0I",85QCN3*2QCQ^\81P-)Q-X@A"__!%>H1$H+V\")5$VE%YU&!> M(NE(1DEF<&*';-HD)Z@[PXB/3AE4V[?.A2A1)FV28:N='D/91%66LI!0P\_^ M@(?*/\;R,_,)(C]8%[/,,+"#!V$:[^(3NV F;2_$U*4QG8;,7*9P%L+$Y2\[ MM\PLV1)E,3ODK";1N&-ZDD+^\@4OH]9*;0JMF\S,C3F-A4YK,F>=A#.A-V-H MQ' FZ)&KN:8^LV+/>G RE0)T'C?WR371M7 [!,6F]12_:;J$0FBA]/2G0ZD7 M4.H-=*(8'9D?&9G1BD:T6AW-)]U &M*%C?2>)1W>1AWIN)-R-*4P-6GE8@JY MD](4C#.]:8O\J%.5MK2G]NL:4(=ZHIP2%9)&/:I!?ZK4)U&PJ4YE'U1A*=6I M6E5P5J5J0;,:1Y;NS*93Q2I7Q9K5LBK-K.Y$ZRO5RM:F_M.M;8VK7.=*U[K: M]:YXS:M>]\K7OOKUKX -K& '2]C"&O:PB$VL8A?+V,8Z]K&0C:QD)TO9REKV MLIC-K&8WR]G.>O:SH VM:$=+VM*:]K2H3:UJ5\O:UKKVM;"-K6QG2]O:VO:V (N,VM:@,! #L! end GRAPHIC 7 image5.gif GRAPHIC begin 644 image5.gif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end

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image3.gif GRAPHIC begin 644 image3.gif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end GRAPHIC 6 image4.gif GRAPHIC begin 644 image4.gif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